Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Klinik und Poliklinik für Urologie am Universitätsklinikum Essen

Anschrift
Hufelandstraße 55
45122 Essen

Funktionen

  • Direktor, Klinik für Urologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 372 - 378
  • Valentin, Birte; Arsov, Christian; Ullrich, Tim; Al-Monajjed, Rouvier; Boschheidgen, Matthias; Hadaschik, Boris A.; Giganti, Francesco; Giessing, Markus; Lopez-Cotarelo, Cristina; Esposito, Irene; Antoch, Gerald; Albers, Peter; Radtke, Jan Philipp; Schimmöller, Lars
    Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer : The Prospective PROMM-AS Study
    In: European Urology Open Science Jg. 59 (2024) S. 30 - 38
  • Weber, Manuel; Fendler, Wolfgang P.; Ravi Kumar, Aravind S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Kretschmer, Alexander; Hekimsoy, Turkay; Brookman-May, Sabine D.; Mundle, Suneel D.; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Herrmann, Ken; Hofman, Michael S.; Eiber, Matthias; Hadaschik, Boris A.
    Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer : An International Multicenter Retrospective Study
    In: European Urology (2024) in press
  • Mahmoud, Osama; Krafft, Ulrich; Al-Nader, Mulham; Heβ, Jochen; Kesch, Claudia; AbdelRazek, Mostafa; Abolyosr, Ahmad; Alsagheer, Gamal A; Mohamed, Omar; Fathi, Atef; Hadaschik, Boris; Tschirdewahn, Stephan; Heß, Jochen A.
    Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion : A systematic review
    In: Arab Journal of Urology Jg. 22 (2024) Nr. 1, S. 61 - 69
  • Pettinella, Francesca; Mariotti, Barbara; Lattanzi, Chiara; Bruderek, Kirsten; Donini, Marta; Costa, Sara; Marini, Olivia; Iannoto, Giulia; Gasperini, Sara; Caveggion, Elena; Castellucci, Monica; Calzetti, Federica; Bianchetto-Aguilera, Francisco; Gardiman, Elisa; Giani, Matteo; Dusi, Stefano; Cantini, Maurizio; Vassanelli, Aurora; Pavone, Denise; Milella, Michele; Pilotto, Sara; Biondani, Pamela; Höing, Benedikt; Schleupner, Marie Carolin; Hussain, Timon; Hadaschik, Boris; Kaspar, Cordelia; Visco, Carlo; Tecchio, Cristina; Koenderman, Leo; Bazzoni, Flavia; Tamassia, Nicola; Brandau, Sven; Cassatella, Marco A.; Scapini, Patrizia
    Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
    In: Cell Reports Medicine (2024) 101380 in press
  • Maurer, Tobias; Thomas, Christian; Hadaschik, Boris
    The DETECT Trial : Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 430 - 431
  • von Ostau, Nicola E.; Martynov, Aleksandr; Schreiber, Janina; Wiesehöfer, Marc; Hadaschik, Boris A.; Temme, Christian; Stang, Andreas; Dankert, Jaroslaw T.; Wiesehöfer, Caroline; Wennemuth, Gunther
    Transient Decrease in Sperm Motility after Plateletpheresis
    In: Exposure and Health (2024) in press
  • Costa, Pedro Fragoso; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Tschirdewahn, Stephan; Moraitis, Alexandros; Radtke, Jan Philipp; Ting, Saskia; Nader, Michael; Wosniack, Jasmin; Kersting, David; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Hadaschik, Boris; Darr, Christopher
    18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 598 - 604
  • Abascal Junquera, Jose M.; Harke, Nina N.; Walz, Jochen C.; Hadaschik, Boris; Adshead, Jim; Everaerts, Wouter; Goffin, Karolien; Grootendorst, Maarten R.; Oldfield, Francesca; Vyas, Kunal; Fusco, Antoni Mestre; Juanpere, Nuria; Vidal-Sicart, Sergi; Fumado, Lluis
    A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer : Preclinical Evaluation and Interim Results From a Multicenter Clinical Trial
    In: Clinical Nuclear Medicine Jg. 48 (2023) Nr. 3, S. 213 - 220
  • Krilaviciute, Agne; Albers, Peter; Lakes, Jale; Radtke, Jan Philipp; Herkommer, Kathleen; Gschwend, Jürgen; Peters, Inga; Kuczyk, Markus; Koerber, Stefan A.; Debus, Jürgen; Kristiansen, Glen; Schimmöller, Lars; Antoch, Gerald; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz; Benner, Axel; Giesel, Frederik; Siener, Roswitha; Arsov, Christian; Hadaschik, Boris; Becker, Nikolaus; Kaaks, Rudolf
    Adherence to a risk-adapted screening strategy for prostate cancer : First results of the PROBASE trial
    In: International Journal of Cancer Jg. 152 (2023) Nr. 5, S. 854 - 864
  • Handke, Analena; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Yang; Hakansson, Alexander; Davicioni, Elai; Hughes, Jason; Song, Hong; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
    In: Journal for ImmunoTherapy of Cancer Jg. 11 (2023) Nr. 10, e007354
  • Pollock, YaoYao; Smith, Matthew R; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Olmos, David; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Brendan; Brookman-May, Sabine D; De Porre, Peter; Mundle, Suneel D; Small, Eric J
    Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    In: Prostate Cancer and Prostatic Diseases Jg. 26 (2023) S. 156 - 161
  • Varadi, Melinda; Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Modos, Orsolya; Szendroi, Attila; Ablat, Jason; Black, Peter C.; Keresztes, David; Csizmarik, Anita; Olah, Csilla; Gaisa, Nadine T.; Kiss, Andras; Timar, Jozsef; Toth, Erika; Csernak, Erzsebet; Gerstner, Arpad; Mittal, Vinay; Karkampouna, Sofia; Kruithof de Julio, Marianna; Gyorffy, Balazs; Bedics, Gabor; Rink, Michael; Fisch, Margit; Nyirady, Peter; Szarvas, Tibor
    Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
    In: Cancer Medicine Jg. 12 (2023) Nr. 7, S. 9041 CA Szarvas - 9054
  • Csizmarik, Anita; Nagy, Nikolett; Keresztes, Dávid; Váradi, Melinda; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
    In: Prostate Cancer and Prostatic Diseases (2023) in press
  • Pollock, YaoYao; Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Olmos, David; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Brendan; Brookman-May, Sabine D.; De Porre, Peter; Mundle, Suneel D.; Small, Eric J.
    Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    In: Prostate Cancer and Prostatic Diseases Jg. 26 (2023) Nr. 4, 813
  • Al-Nader, Mulham; Radtke, Jan Philipp; Püllen, Lukas; Darr, Christopher; Kesch, Claudia; Heß, Jochen; Krafft, Ulrich; Hadaschik, Boris; Harke, Nina; Mahmoud, Osama
    Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN)
    In: Journal of Robotic Surgery Jg. 17 (2023) Nr. 5, S. 2089 - 2098
  • Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W.; Fornara, Paolo; Kurth, Jens; Neels, O.; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J.
    DGN-Handlungsempfehlung (S1-Leitlinie) : PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms - Stand: 01/2022 - AWMF-Registernummer: 031-055
    In: Nuklearmedizin = Nuclear Medicine Jg. 62 (2023) Nr. 1, S. 5 - 19
  • Yirga, Leubet; Hadaschik, Boris; Püllen, Lukas
    Das Primärstaging mittels PSMA-PET verbessert die Vorhersage von Prostatakarzinomrezidiven
    In: Die Urologie (2023) in press
  • Saner, Yasemin Melisa; Wiesenfarth, Manuel; Weru, Vivienn; Ladyzhensky, Boris; Tschirdewahn, Stephan; Püllen, Lukas; Bonekamp, David; Reis, Henning; Krafft, Ulrich; Heß, Jochen A.; Kesch, Claudia; Darr, Christopher; Forsting, Michael; Wetter, Axel; Umutlu, Lale; Haubold, Johannes; Hadaschik, Boris; Radtke, Jan Philipp
    Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy : A Prospective Randomized Trial
    In: European Urology Oncology Jg. 6 (2023) Nr. 1, S. 49 - 55
  • Barakat, Bara; Gauger, Ulrich; Rehme, Christian; Hadaschik, Boris; Wolff, Ingmar; Hijazi, Sameh
    Diagnosis of female urethral diverticulum using pelvic floor ultrasound and comparison with voiding cystourethrogram (imaging study)
    In: International Urogynecology Journal Jg. 34 (2023) Nr. 2, S. 563 - 569
  • Krilaviciute, Agne; Becker, Nikolaus; Lakes, Jale; Radtke, Jan Philipp; Kuczyk, Markus; Peters, Inga; Harke, Nina N.; Debus, Jürgen; Koerber, Stefan A.; Herkommer, Kathleen; Gschwend, Jürgen E; Meissner, Valentin H.; Benner, Axel; Seibold, Petra; Kristiansen, Glen; Hadaschik, Boris; Arsov, Christian; Schimmöller, Lars; Giesel, Frederik Lars; Antoch, Gerald; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz-Peter; Kaaks, Rudolf; Albers, Peter
    Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
    In: European Urology Oncology Jg. 6 (2023) Nr. 6, S. 566 - 573
  • Váradi, Melinda; Horváth, Orsolya; Módos, Orsolya; Fazekas, Tamás; Grunewald, Camilla M.; Niegisch, Günter; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Olah, Csilla; Maráz, Anikó; Furka, Andrea; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice : results of a multicentric, retrospective study
    In: Scientific Reports Jg. 13 (2023) Nr. 1, 17378
  • Zschäbitz, Stefanie; Biernath, Nadine; Hilser, Thomas; Höllein, Alexander; Zengerling, Friedemann; Cascucelli, Jozefina; Paffenholz, Pia; Seidl, Daniel; Lutz, Christoph; Schlack, Katrin; Kingreen, Dorothea; Klümper, Niklas; Ivanyi, Philipp; von Amsberg, Gunhild; Heers, Hendrik; Roghmann, Florian; Tauber, Robert L.; Cathomas, Richard; Hofer, Luisa; Niegisch, Günter; Klee, Melanie; Ehrenberg, Roland; Hassler, Andreas; Hadaschik, Boris; Grünwald, Viktor; Darr, Christopher
    Enfortumab Vedotin in Metastatic Urothelial Carcinoma : Survival and Safety in a European Multicenter Real-world Patient Cohort
    In: European Urology Open Science Jg. 53 (2023) S. 31 - 37
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716
  • Pöttgen, Christoph; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago Garcia, Alina; Krafft, Ulrich; Hadaschik, Boris; Khouya, Aymane; Stuschke, Martin
    Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer : Answers from a Prospective Registry
    In: Cancers Jg. 15 (2023) Nr. 20, 4933
  • Kowalski, Christoph; Sibert, Nora Tabea; Hammerer, Peter; Wesselmann, Simone; Feick, Günter; Carl, Ernst-Günther; Klotz, Theodor; Apel, Hendrik; Dieng, Sebastian; Nyarangi-Dix, Joanne; Knoll, Thomas; Reike, Moritz Johannes; Duwe, Gregor; Bartolf, Elisabeth; Steiner, Thomas; Borowitz, Rainer; Lümmen, Gerd; Seitz, Anna Katharina; Pfitzenmaier, Jesco; Aziz, Atiqullah; Brock, Marko; Berger, Frank Peter; Kaftan, Björn Theodor; Grube, Christian; Häfner, Tim; Hamza, Amir; Schmelz, Hans; Haas, Jürgen; Lenart, Sebastian; Lafita, Anselm; Sippel, Carsten; Winter, Alexander; Kedia, George; Hadaschik, Boris; Varga, Zoltan; Buse, Stephan; Richter, Matthias; Distler, Florian; Simon, Jörg; Wiegel, Thomas; Baltes, Stefan; Janitzky, Andreas; Sommer, Jens Peter; Hijazi, Sameh; Fülkell, Philipp; Harke, Nina N.; Bolenz, Christian; Khalil, Christian; Breidenbach, Clara; Tennstedt, Pierre; Burchardt, Martin
    Harninkontinenz nach radikaler Prostatektomie beim Prostatakarzinom  : Aktuelle Daten von 17.149 Patienten aus 125 zertifizierten Zentren
    In: Die Urologie (2023) in press
  • Darr, Christopher; Hilser, Thomas; Kesch, Claudia; Isgandarov, Aykhan; Reis, Henning; Wahl, Milan; Kasper-Virchow, Isabel; Hadaschik, Boris; Grünwald, Viktor
    Immune-Checkpoint-Inhibitor Therapy : Principles and Relevance of Biomarkers for Pathologists and Oncologists
    In: Advances in Anatomic Pathology Jg. 30 (2023) Nr. 3, S. 160 - 166
  • Darr, Christopher; Costa, Pedro Fragoso; Kahl, Theresa; Moraitis, Alexandros; Engel, Jenna; Al-Nader, Mulham; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Maurer, Tobias; Köhler, Daniel; Klutmann, Susanne; Falkenbach, Fabian; Kleesiek, Jens; Fendler, Wolfgang P.; Hadaschik, Boris; Herrmann, Ken
    Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
    In: European Urology Open Science Jg. 54 (2023) S. 28 - 32
  • Khalil, Dalia Ahmad; Wulff, Jörg; Jazmati, Danny; Geismar, Dirk; Bäumer, Christian; Kramer, Paul-Heinz; Steinmeier, Theresa; Schulze-Schleithoff, Stefanie; Tschirdewahn, Stephan; Hadaschik, Boris; Timmermann, Beate
    Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? : A Dosimetric and Radiobiological Comparison Study
    In: Current Oncology Jg. 30 (2023) Nr. 1, S. 758 - 768
  • Seifert, Robert; Telli, Tugce; Hadaschik, Boris; Fendler, Wolfgang; Kuo, Phillip H.; Herrmann, Ken
    Is ¹⁸F-FDG PET Needed to Assess ¹⁷⁷Lu-PSMA Therapy Eligibility? : A VISION-like, Single-Center Analysis
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 731 - 737
  • Meyer, Lena; Bohlscheid, Andreas; Lemmer, Oscar; Van De Plas, Jeroen; Leboutte, Francois; Hadaschik, Boris A.; Neisius, Andreas; Willinek, Winfried A.
    MR-Guided Transurethral Ultrasound Ablation of Prostate Cancer : Initial Experience of Monitoring Tumor Response by Dynamic Apparent Diffusion Coefficient Measurements at 3.0 T
    In: Urologia Internationalis Jg. 107 (2023) Nr. 7, S. 684 - 692
  • Posdzich, Philip; Darr, Christopher; Hilser, Thomas; Wahl, Milan; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Metastatic Prostate Cancer : A Review of Current Treatment Options and Promising New Approaches
    In: Cancers Jg. 15 (2023) Nr. 2, 461
  • Boschheidgen, Matthias; Albers, Peter; Schlemmer, Heinz-Peter; Hellms, Susanne; Bonekamp, David; Sauter, Andreas; Hadaschik, Boris; Krilaviciute, Agne; Radtke, Jan Philipp; Seibold, Petra; Lakes, Jale; Arsov, Christian; Gschwend, Jürgen E.; Herkommer, Kathleen; Makowski, Marcus; Kuczyk, Markus A.; Wacker, Frank; Harke, Nina; Debus, Jürgen; Körber, Stefan A.; Benner, Axel; Kristiansen, Glen; Giesel, Frederik L.; Antoch, Gerald; Kaaks, Rudolf; Becker, Nikolaus; Schimmöller, Lars
    Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years : Results from the First Screening Round of the PROBASE Trial
    In: European Urology Jg. 85 (2023) Nr. 2, S. 105 - 111
  • Isgandarov, A.; Darr, C.; Posdzich, P.; Hermann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Neue Therapieansätze und Studienübersicht beim metastasierten hormonsensitiven Prostatakarzinom
    In: Die Urologie Jg. 62 (2023) Nr. 4, S. 369 - 375
  • Pomykala, K.L.; Hadaschik, Boris; Sartor, O.; Gillessen, S.; Sweeney, C.J.; Maughan, T.; Hofman, M.S.; Herrmann, Ken
    Next generation radiotheranostics promoting precision medicine
    In: Annals of Oncology Jg. 34 (2023) Nr. 6, S. 507 - 519
  • Cathomas, Richard; Rothschild, Sacha I.; Hayoz, Stefanie; Bubendorf, Lukas; Özdemir, Berna C.; Kiss, Bernhard; Erdmann, Andreas; Aeppli, Stefanie; Mach, Nicolas; Strebel, Räto T; Hadaschik, Boris; Berthold, Dominik; John, Hubert; Zihler, Deborah; Schmid, Mathias; Alborelli, Ilaria; Schneider, Martina; Musilova, Jana; Spahn, Martin; Petrausch, Ulf
    Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma : Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 33, S. 5131 - 5139
  • Yirga, Leubet; Hadaschik, Boris; Burger, Maximilian; Püllen, Lukas
    Photodynamische transurethrale Resektion der Blase (TURB): mehr Schein als Sein : Ein Kommentar zur randomisierten Studie
    In: Die Urologie Jg. 62 (2023) Nr. 2, S. 181 - 183
  • Széles, Ádám; Fazekas, Tamás; Váncsa, Szilard; Váradi, Melinda; Kovács, Petra Terézia; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Csizmarik, Anita; Hegyi, Péter; Váradi, Alex; Nyirády, Péter; Szarvas, Tibor
    Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysis
    In: Cancer Immunology, Immunotherapy Jg. 72 (2023) Nr. 5, S. 1061 - 1073
  • Olah, Csilla; Reis, Henning; Hoffmann, Michèle J.; Mairinger, Fabian; Ting, Saskia; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Nyirady, Peter; Varadi, Melinda; Győrffy, Balázs; Kiss, Andras; Szekely, Eszter; Sjödahl, Gottfrid; Szarvas, Tibor
    Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
    In: Cancer Medicine Jg. 12 (2023) Nr. 5, S. 5222 - 5232
  • Deivasigamani, Sriram; Kotamarti, Srinath; Rastinehad, Ardeshir R.; Sanchez Salas, Rafael; de la Rosette, J.J.M.C.H.; Lepor, Herbert; Pinto, Peter; Ahmed, Hashim U.; Gill, Inderbir; Klotz, Laurence; Taneja, Samir S.; Emberton, Mark; Lawrentschuk, Nathan; Wysock, James; Feller, John F.; Crouzet, Sebastien; Kumar M., Praveen; Seguier, Denis; Adams, Eric S.; Michael, Zoe; Abreu, Andre; Jack Tay, Kae; Ward, John F.; Shinohara, Katsuto; Katz, Aaron E.; Villers, Arnauld; Chin, Joseph L.; Stricker, Phillip D.; Baco, Eduard; Macek, Petr; Ahmad, Ardalan E.; Chiu, Peter K.F.; Crawford, E. David; Rogers, Craig G.; Futterer, Jurgen J.; Rais-Bahrami, Soroush; Robertson, Cary N.; Hadaschik, Boris; Marra, Giancarlo; Valerio, Massimo; Chong, Kian Tai; Kasivisvanathan, Veeru; Tan, Wei Phin; Lomas, Derek; Walz, Jochen; Guimaraes, Gustavo Cardoso; Mertziotis, Nikos I.; Becher, Ezequiel; Finelli, Antonio; Kasraeian, Ali; Lebastchi, Amir H.; Vora, Anup; Rosen, Mark A.; Bakir, Baris; Arcot, Rohit; Yee, Samuel; Netsch, Christopher; Meng, Xiaosong; de Reijke, Theo M.; Tan, Yu Guang; Regusci, Stefano; Benjamin, Tavya G.R.; Olivares, Ruben; Noureldin, Mohamed; Bianco, Fernando J.; Sivaraman, Arjun; Kim, Fernando J.; Given, Robert W.; Dason, Shawn; Sheetz, Tyler J.; Shoji, Sunao; Schulman, Ariel; Royce, Peter; Shah, Taimur T.; Scionti, Stephen; Salomon, Georg; Laguna, Pilar; Tourinho-Barbosa, Rafael; Aminsharifi, Alireza; Cathelineau, Xavier; Gontero, Paolo; Stabile, Armando; Grummet, Jeremy; Ledbetter, Leila; Graton, Margaret; Jones, J. Stephen; Polascik, Thomas J.
    Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer : A Focal Therapy Society Best Practice Statement
    In: European Urology Jg. 84 (2023) Nr. 6, S. 547 - 560
  • Maier, Daniel; Vehreschild, Jörg Janne; Uhl, Barbara; Meyer, Sandra; Berger-Thürmel, Karin; Boerries, Melanie; Braren, Rickmer; Grünwald, Viktor; Hadaschik, Boris; Palm, Stefan; Singer, Susanne; Stuschke, Martin; Juárez, David; Delpy, Pierre; Lambarki, Mohamed; Hummel, Michael; Engels, Cäcilia; Andreas, Stefanie; Gökbuget, Nicola; Ihrig, Kristina; Burock, Susen; Keune, Dietmar; Eggert, Angelika; Keilholz, Ulrich; Schulz, Hagen; Büttner, Daniel; Löck, Steffen; Krause, Mechthild; Esins, Mirko; Ressing, Frank; Schuler, Martin; Brandts, Christian; Brucker, Daniel P.; Husmann, Gabriele; Oellerich, Thomas; Metzger, Patrick; Voigt, Frederik; Illert, Anna L.; Theobald, Matthias; Kindler, Thomas; Sudhof, Ursula; Reckmann, Achim; Schwinghammer, Felix; Nasseh, Daniel; Weichert, Wilko; von Bergwelt-Baildon, Michael; Bitzer, Michael; Malek, Nisar; Öner, Öznur; Schulze-Osthoff, Klaus; Bartels, Stefan; Haier, Jörg; Ammann, Raimund; Schmidt, Anja Franziska; Guenther, Bernd; Janning, Melanie; Kasper, Bernd; Loges, Sonja; Stilgenbauer, Stephan; Kuhn, Peter; Tausch, Eugen; Runow, Silvana; Kerscher, Alexander; Neumann, Michael; Breu, Martin; Lablans, Martin; Serve, Hubert
    Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
    In: European Journal of Epidemiology Jg. 38 (2023) Nr. 5, S. 573 - 586
  • Klümper, Niklas; Eckstein, Markus; Hölzel, Michael; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Re: First-in-Human Study of the Radioligand ⁶⁸Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma : Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT
    In: European Urology Jg. 84 (2023) Nr. 5, S. 514 - 515
  • Gafita, Andrei; Djaileb, Loïc; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea
    Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
    In: Radiology Jg. 308 (2023) Nr. 1, e222148
  • Kesch, Claudia; Pantea, Vlad; Soeterik, Timo; Marquis, Alessandro; la Bombarda, Giulia; Morlacco, Allesandro; Barletta, Francesco; Radtke, Jan Philipp; Darr, Christopher; Preisser, Felix; Zattoni, Fabio; Marra, Giancarlo; van den Bergh, Roderik C. N.; Hadaschik, Boris; Gandaglia, Giorgio
    Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy : a multicenter analysis
    In: World Journal of Urology Jg. 41 (2023) Nr. 2, S. 427 - 434
  • Seifert, Robert; Emmett, Louise; Rowe, Steven P.; Herrmann, Ken; Hadaschik, Boris; Calais, Jeremie; Giesel, Frederik L.; Reiter, Robert; Maurer, Tobias; Heck, Matthias; Gafita, Andrei; Morris, Michael J.; Fanti, Stefano; Weber, Wolfgang A.; Hope, Thomas A.; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    In: European Urology Jg. 83 (2023) Nr. 5, S. 405 - 412
  • Fortuin, Ansje; van Asten, Jack; Veltien, Andor; Philips, Bart; Hambrock, Thomas; Johst, Sören; Orzada, Stephan; Hadaschik, Boris; Quick, Harald; Barentsz, Jelle; Maas, Marnix; Scheenen, Tom
    Small Suspicious Lymph Nodes Detected on Ultrahigh-field Magnetic Resonance Imaging (MRI) in Patients with Prostate Cancer with High Risk of Nodal Metastases : The First In-patient Study on Ultrasmall Superparamagnetic Iron Oxide-enhanced 7T MRI
    In: European Urology Jg. 83 (2023) Nr. 4, S. 375 - 377
  • Seifert, Robert; Gafita, Andrei; Telli, Tugce; Voter, Andrew; Herrmann, Ken; Pomper, Martin; Hadaschik, Boris; Rowe, Steven P.; Fendler, Wolfgang
    Standardized PSMA-PET Imaging of Advanced Prostate Cancer
    In: Seminars in Nuclear Medicine Jg. 54 (2023) Nr. 1, S. 60 - 68
  • Handke, Analena Elisa; Albers, Peter; Schimmöller, Lars; Bonekamp, David; Asbach, Patrick; Schlemmer, Heinz-Peter; Hadaschik, Boris; Radtke, Jan Philipp
    Systematische oder gezielte Fusionsbiopsie der Prostata
    In: Die Urologie Jg. 62 (2023) Nr. 5, S. 464 - 472
  • Fazekas, Tamás; Széles, Ádám D.; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Váradi, Alex; Kói, Tamás; Lang, Zsolt; Ács, Nándor; Kopa, Zsolt; Hegyi, Péter; Hadaschik, Boris; Grünwald, Viktor; Nyirády, Péter; Szarvas, Tibor
    Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients : A systematic review and meta-analysis
    In: Prostate Cancer and Prostatic Diseases Jg. 26 (2023) Nr. 4, S. 665 - 672
  • Seifert, Robert; Telli, Tugce; Opitz, Marcel; Barbato, Francesco; Berliner, Christoph; Nader, Michael; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang
    Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 738 - 743
  • Olah, Csilla; Hahnen, Christina; Nagy, Nikolett; Musial, Joanna; Varadi, Melinda; Nyiro, Gabor; Gyorffy, Balazs; Hadaschik, Boris; Rawitzer, Josefine; Ting, Saskia; Sjödahl, Gottfrid; Hoffmann, Michéle J.; Reis, Henning; Szarvas, Tibor
    A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genes
    In: International Journal of Cancer Jg. 150 (2022) Nr. 5, S. 856 - 867
  • Arsov, Christian; Albers, Peter; Herkommer, Kathleen; Gschwend, Jürgen; Imkamp, Florian; Peters, Inga; Kuczyk, Markus; Hadaschik, Boris; Kristiansen, Glen; Schimmöller, Lars; Antoch, Gerald; Rummeny, Ernst; Wacker, Frank; Schlemmer, Heinz; Benner, Axel; Siener, Roswitha; Kaaks, Rudolf; Becker, Nikolaus
    A randomized trial of risk-adapted screening for prostate cancer in young men : Results of the first screening round of the PROBASE trial
    In: International Journal of Cancer Jg. 150 (2022) Nr. 11, S. 1861 - 1869
  • Chowdhury, Simon; Oudard, Stephane; Uemura, Hiroji; Joniau, Steven; Dearden, Lindsay; Capone, Camille; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris A.
    Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer : Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
    In: Advances in Therapy Jg. 39 (2022) Nr. 1, S. 518 - 531
  • Chowdhury, Simon; Oudard, S.; Uemura, H.; Joniau, S.; Dearden, L.; Capone, C.; van Sanden, S.; Diels, J.; Hadaschik, Boris
    Apalutamide compared with darolutamide for the treatment of non-metastatic castration resistant prostate cancer : efficacy and tolerability in a matching-adjusted indirect comparison
    In: Onkourologija (= Cancer Urology) Jg. 18 (2022) Nr. 1, S. 77 - 89
  • Deutsch, Sebastian; Hadaschik, Boris; Lebentrau, Steffen; Ubrig, Burkhard; Burger, Max; May, Matthias
    Clinical Importance of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection : A Systematic Review and Meta-Analysis
    In: Urologia Internationalis Jg. 106 (2022) Nr. 1, S. 28 - 34
  • Rehme, Christian R.; Fritsch, Beatrix; Thomas, Luca; Istin, Stefan; Burchert, Carolin; Hummel, Bastian; Baleanu-Curaj, Bogdan; Reis, Henning; Szarvas, Tibor; Rübben (H.), Herbert; Hadaschik, Boris; Niedworok, Christian
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patients
    In: International Urology and Nephrology Jg. 54 (2022) Nr. 1, S. 71 - 79
  • Krafft, Ulrich; Mahmoud, O.; Heß, Jochen A.; Radtke, Jan Phillipp; Panic, Andrej; Püllen, Lukas; Darr, C.; Kesch, C.; Szarvas, Tibor; Rehme, Christian R.; Hadaschik, Boris; Tschirdewahn, Stephan
    Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
    In: Langenbeck's Archives of Surgery Jg. 407 (2022) Nr. 3, S. 1233 - 1240
  • Keresztes, Dávid; Csizmarik, Anita; Nagy, Nikolett; Módos, Orsolya; Fazekas, Tamás; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Sevcenco, Sabina; Kramer, Gero; Shariat, Shahrokh; Küronya, Zsófia; Takács, László; Tornyi, Ilona; Lázár, József; Hadaschik, Boris; Lászik, András; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer
    In: Journal of Cellular and Molecular Medicine Jg. 26 (2022) Nr. 4, S. 1332 - 1337
  • Barakat, Bara; Franke, Knut; Hijazi, Sameh; Wolff, Ingmar; Hadaschik, Boris; Rehme, Christian R.
    Correlation between symptoms and imaging findings including pelvic floor ultrasound to improve the symptom-based diagnosis of female urethral diverticulum (CHECK-UD study)
    In: International Urogynecology Journal Jg. 33 (2022) Nr. 8, S. 2267 - 2274
  • Saad, Fred; Small, Eric J.; Feng, Felix Y.; Graff, Julie N.; Olmos, David; Hadaschik, Boris; Oudard, Stéphane; Londhe, Anil; Bhaumik, Amitabha; Lopez-Gitlitz, Angela; Thomas, Shibu; Mundle, Suneel D.; Chowdhury, Simon; Smith, Matthew R.
    Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN
    In: European Urology Jg. 81 (2022) Nr. 2, S. 184 - 192
  • Ahmad Khalil, Dalia; Jazmati, Danny; Geismar, Dirk; Wulff, Jörg; Bäumer, Christian; Kramer, Paul Heinz; Steinmeier, Theresa; Schulze Schleitthoff, Stefanie; Plaude, Sandija; Bischoff, Martin; Tschirdewahn, Stephan; Hadaschik, Boris; Timmermann, Beate
    Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
    In: Radiation Oncology Jg. 17 (2022) Nr. 1, 64
  • Fanti, Stefano; Briganti, Alberto; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Kunikowska, Jolanta; Maurer, Tobias; MacLennan, Steven; Mottet, Nicolas; Murphy, Declan G.; Oprea-Lager, Daniela E.; O'Sullivan, Joe M.; Oyen, Wim J G; Rouvière, Olivier; Sartor, Oliver; Stenzl, Arnulf; Van Poppel, Hendrik; Walz, Jochen; Witjes, Wim; Bjartell, Anders
    EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy
    In: European Urology Oncology Jg. 5 (2022) Nr. 5, S. 530 - 536
  • Kovács, Petra Terézia; Mayer, Tamás; Csizmarik, Anita; Váradi, Melinda; Oláh, Csilla; Széles, Ádám; Tschirdewahn, Stephan; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Riesz, Péter; Szarvas, Tibor
    Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines Jg. 10 (2022) Nr. 3, 698
  • Oudard, Stéphane; Hadaschik, Boris; Saad, Fred; Cella, David; Basch, Ethan; Graff, Julie N.; Uemura, Hiroji; Dibaj, Shiva; Li, Susan; Brookman-May, Sabine D.; De Porre, Peter; Bevans, Katherine B.; Trudeau, Jeremiah J.; Small, Eric J.; Smith, Matthew R.
    Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    In: European Urology Focus Jg. 8 (2022) Nr. 4, S. 958 - 967
  • Széles, Ádám; Kovács, Petra Terézia; Csizmarik, Anita; Váradi, Melinda; Riesz, Péter; Fazekas, Tamás; Váncsa, Szilárd; Hegyi, Péter; Oláh, Csilla; Tschirdewahn, Stephan; Darr, Christopher; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Horváth, Orsolya; Nyirády, Péter; Szarvas, Tibor
    High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines Jg. 10 (2022) Nr. 10, 2560
  • Struck, Julian P.; Schnoor, Maike; Schulze, Andrea; Hupe, Marie C.; Ozimek, Tomasz; Oppolzer, Immanuel A.; Schnabel, Marco J.; Burger, Maximilian; Darr, Christopher; Gruenwald, Viktor; Hadaschik, Boris; Weinke, Maximilian; Kuebler, Hubert; Klockenbusch, Jonas C.; Grabbert, Markus T.; Gratzke, Christian; Kramer, Mario W.; Katalinic, Alexander; Merseburger, Axel S.
    Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy : a multicenter study in German university hospitals
    In: World Journal of Urology Jg. 40 (2022) Nr. 2, S. 409 - 418
  • Harke, Nina; Kuczyk, Markus A.; Huusmann, Stephan; Schiefelbein, Frank; Schneller, Andreas; Schoen, Georg; Wiesinger, Clemens; Pfuner, Jacob; Ubrig, Burkhard; Gloger, Simon; Osmonov, Daniar; Eraky, Ahmed; Witt, Jörn H.; Liakos, Nikolaos; Wagner, Christian; Hadaschik, Boris; Radtke, Jan-Philipp; Al Nader, Mulham; Imkamp, Florian; Siemer, Stefan; Stöckle, Michael; Zeuschner, Philip
    Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes : A Multicenter Analysis of 2500 Patients
    In: European Urology Open Science Jg. 46 (2022) S. 45 - 52
  • Ohlmann, Carsten; Grünwald, V.; Hadaschik, Boris
    Kombinierte Hormontherapie beim lokal begrenzten Prostatakarzinom
    In: Die Urologie Jg. 61 (2022) Nr. 9, S. 660 - 662
  • Harke, Nina; Wagner, Christian; Hermann, Robert M.; Hadaschik, Boris; Radtke, Jan Philipp; Altay-Langguth, Alev; Aufderklamm, Stefan; Bach, Christian; Becker-Schiebe, Martina; Blana, Andreas; Bruns, Frank; Buse, Stephan; Combs, Stephanie E.; Engels, Christina L.; Ezzibdeh, Emad; Fiedler, Marcel; Fischer, Laura-Anna; Farzat, Mahmoud; Frismann, Alexander; Heck, Matthias M.; Henkenberens, Christoph; Roesch, Marie C.; Kading, Christoph; Klautke, Gunther; Krausewitz, Philipp; Kuczyk, Markus A.; Leitsmann, Conrad; Lettmaier, Sebastian; Mahjoub, Samy; Manseck, Andreas; Medenwald, Daniel; Meyer, Andreas; Micke, Oliver; Moritz, Rudolf; Ott, Marcel; Peters, Inga; Pokupic, Sasa; Porres, Daniel; Preisser, Felix; Reichel, Kathrin; Schneider, Andreas; Schwentner, Christian; Scobioala, Sergiu; Truss, Michael; Wegener, Daniel; Wezel, Felix; Willborn, Kay; Witt, Jorn H.; Wittig, Andrea; Wittlinger, Michael; Wolff, Hendrik A.; Zimmermanns, Volker; Christiansen, Hans
    Lessons learned after one year of COVID-19 from a urologist and radiotherapist view : A German survey on prostate cancer diagnosis and treatment
    In: PLoS ONE Jg. 17 (2022) Nr. 6, e0269827
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0) : An International Multicenter Study
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 11, S. 1651 - 1658
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Radiologie Jg. 62 (2022) Nr. 10, S. 875 - 884
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Onkologie Jg. 28 (2022) Nr. 7, S. 612 - 622
  • Kibel, Adam S.; Gleave, Martin; Brookman-May, Sabine D.; Kim, Won; Evans, Christopher P.; Efstathiou, Eleni; Kantoff, Philip W.; Ross, Ashley; Shore, Neal D.; Briganti, Alberto; Hadaschik, Boris; Heidenreich, Axel; Rooney, Oliver Brendan; Tian, Shaozhou Ken; Wetherhold, Lisa; Xu, Weichun; Parsons, J. Kellogg; Yeruva, Kesav; Taplin, Mary-Ellen
    PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC)
    In: Journal of Clinical Oncology (JCO) (2022) TPS285
  • Wessolly, Michael; Mairinger, Fabian D.; Herold, Thomas; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
    In: Genes Jg. 13 (2022) Nr. 3, 422
  • Csizmarik, Anita; Keresztes, Dávid; Nagy, Nikolett; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Jurányi, Zsolt; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
    In: International Journal of Cancer Jg. 151 (2022) Nr. 8, S. 1405 - 1419
  • Costa, Pedro Fragoso; Fendler, Wolfgang; Herrmann, Ken; Sandach, Patrick; Grafe, Hong; Grootendorst, Maarten R.; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Radtke, Jan P.; Tschirdewahn, Stephan; Hadaschik, Boris; Darr, Christopher
    Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 9, S. 1349 - 1356
  • Grünwald, Viktor; Ohlmann, Carsten-Henning; Hadaschik, Boris
    Re: Abiraterone Acetate and Prednisolone With or Without Enzalutamide for High-risk Non-metastatic Prostate Cancer : A Meta-analysis of Primary Results from Two Randomized Controlled Phase 3 Trials of the STAMPEDE Platform Protocol
    In: European Urology Jg. 81 (2022) Nr. 6, S. 621
  • Kesch, Claudia; Hadaschik, Boris
    Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer : The ENACT Randomized Clinical Trial
    In: European Urology Jg. 82 (2022) Nr. 5, S. 572
  • Seifert, Robert; Sandach, Patrick; Kersting, David; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Sunderland, John J.; Pollard, Janet H.
    Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 746 - 753
  • Barakat, Bara; Rehme, Christian R.; Hadaschik, Boris
    Reply to Nikolaos Grivas, Nikolaos Kalampokis, Markos Karavitakis, Ioannis Leotsakos, Ioannis Katafigiotis, and Henk van der Poel’s Letter to the Editor re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003
    In: European Urology Focus Jg. 8 (2022) Nr. 5, S. 1556
  • Püllen, Lukas; Kaspar, Cordelia; Panic, Andrej; Heß, Jochen A.; Reis, Henning; Szarvas, Tibor; Radtke, Jan Philipp; Krafft, Ulrich; Darr, Christopher; Hadaschik, Boris; Tschirdewahn, Stephan
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre Cohort
    In: Urologia Internationalis Jg. 106 (2022) S. 638 - 643
  • Barakat, Bara; Othman, Hazem; Gauger, Ulrich; Wolff, Ingmar; Hadaschik, Boris; Rehme, Christian R.
    Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy : Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis
    In: European Urology Focus Jg. 8 (2022) Nr. 4, S. 1060 - 1071
  • Reis, Henning; Skottky, Silke; Hager, Thomas; Hadaschik, Boris; Waue, Veronika; Zwönitzer, Ralf
    Strukturierte Befundung am Beispiel des Prostatakarzinoms  : Selbstentwicklung einer digitalen Lösung für Prostatastanzbiopsien
    In: Die Pathologie Jg. 43 (2022) Nr. Suppl. 1, S. 94 - 100
  • Ingenwerth, Marc; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer
    In: Current Molecular Medicine Jg. 22 (2022) Nr. 10, S. 941 - 949
  • Darr, Christopher; Finis, Friederike; Wiesenfarth, Manuel; Giganti, Francesco; Tschirdewahn, Stephan; Krafft, Ulrich; Kesch, Claudia; Bonekamp, David; Forsting, Michael; Wetter, Axel; Reis, Henning; Hadaschik, Boris; Haubold, Johannes; Radtke, Jan Philipp
    Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy : A Feasibility Study
    In: European Urology Oncology Jg. 5 (2022) Nr. 3, S. 357 - 361
  • Murray, Jacob M.; Wiegand, Bodo; Hadaschik, Boris; Herrmann, Ken; Kleesiek, Jens
    Virtual Biopsy : Just an AI Software or a Medical Procedure?
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 4, S. 511 - 513
  • Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Graff, Julie N.; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; De Porre, Peter; Smith, Andressa A.; Brookman-May, Sabine D.; Li, Susan; Zhang, Ke; Rooney, Brendan; Lopez-Gitlitz, Angela; Small, Eric J.
    Apalutamide and Overall Survival in Prostate Cancer
    In: European Urology Jg. 79 (2021) Nr. 1, S. 150 - 158
  • Feng, Felix Y.; Thomas, Shibu; Saad, Fred; Gormley, Michael; Yu, Margaret K.; Ricci, Deborah S.; Rooney, Brendan; Brookman-May, Sabine; McCarthy, Sharon; Olmos, David; Chowdhury, Simon; Hadaschik, Boris; Liu, Yang; Davicioni, Elai; Smith, Matthew R.; Small, Eric J.
    Association of molecular subtypes with differential outcome to apalutamide treatment in nonmetastatic castration-resistant prostate cancer
    In: JAMA Oncology Jg. 7 (2021) Nr. 7, S. 1005 - 1014
  • Collamati, Francesco; van Oosterom, Matthias N.; Hadaschik, Boris; Fragoso Costa, Pedro; Darr, Christopher
    Beta radioguided surgery: towards routine implementation?
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 65 (2021) Nr. 3, S. 229 - 243
  • Krafft, Ulrich; Hirner (L.), Lucas; Darr, C.; Mahmoud, O.; Hadaschik, Boris; Rehme, Christian R.
    Botulinum Toxin A in Pediatric Day-Time Lower Urinary Tract Conditions : A Single Center Experience
    In: Journal of Urology and Renal Diseases Jg. 6 (2021) Nr. 6, 1236
  • Szarvas, Tibor; Csizmarik, Anita; Fazekas, Tamás; Hüttl, András; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Püllen, Lukas; Jurányi, Zsolt; Kocsis, Zsuzsa; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnieszka; Kramer, Gero
    Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer
    In: BJU International (BJUI) Jg. 127 (2021) Nr. 1, S. 44 - 55
  • Fanti, Stefano; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Maurer, Tobias; MacLennan, Steven; Oprea-Lager, Daniela E.; Oyen, Wim Jg; Rouvière, Olivier; Mottet, Nicolas; Bjartell, Anders
    Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 469 - 476
  • Tschirdewahn, Stephan; Wiesenfarth, Manuel; Bonekamp, David; Püllen, Lukas; Reis, Henning; Panic, Andrej; Kesch, Claudia; Darr, Christopher; Heß, Jochen A.; Giganti, Francesco; Moore, Caroline M.; Guberina, Nika; Forsting, Michael; Wetter, Axel; Hadaschik, Boris; Radtke, Jan Philipp
    Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy
    In: European Urology Focus Jg. 7 (2021) Nr. 6, S. 1300 - 1307
  • Roth, Rebecca; Dieng, Sebastian; Oesterle, Alisa; Feick, Günter; Carl, Günther; Hinkel, Andreas; Steiner, Thomas; Kaftan, Björn Theodor; Kunath, Frank; Hadaschik, Boris; Oostdam, Simba-Joshua; Palisaar, Rein Jüri; Koralewski, Mateusz; Beyer, Burkhard; Haben, Björn; Tsaur, Igor; Wesselmann, Simone; Kowalski, Christoph
    Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment
    In: World Journal of Urology Jg. 39 (2021) Nr. 1, S. 27 - 36
  • Scharl, S.; Hadaschik, Boris; Wiegel, T.; Thomas, C.
    Die Therapie des primär oligometastasierten Prostatakarzinoms
    In: Der Urologe Jg. 60 (2021) Nr. 12, S. 1527 - 1533
  • Staniszewska, Magdalena; Iking, Janette; Lückerath, Katharina; Hadaschik, Boris; Herrmann, Ken; Ferdinandus, Justin; Fendler, Wolfgang
    Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
    In: Nuclear Medicine and Biology Jg. 96-97 (2021) S. 101 - 111
  • Stuschke, Martin; Hadaschik, Boris
    Elektive Strahlentherapie pelviner Lymphknoten beim High-risk-Prostatakarzinom? : Bewertung der Relation zwischen der relativen Risikoreduktion eines PSA-Rezidivs (prostataspezifisches Antigen) innerhalb von 5 Jahren und einem absoluten Überlebensvorteil
    In: Der Urologe Jg. 60 (2021) Nr. 8, S. 1051 - 1053
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14, 7431
  • Kesch, Claudia; Yirga, Leubet; Dendl, Katharina; Handke, Analena; Darr, Christopher; Krafft, Ulrich; Radtke, Jan Philipp; Tschirdewahn, Stephan; Szarvas, Tibor; Fazli, Ladan; Gleave, Martin; Giesel, Frederik L.; Haberkorn, Uwe; Hadaschik, Boris
    High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 385 - 389
  • Krafft, Ulrich; Olah, Csilla; Reis, Henning; Kesch, Claudia; Darr, Christopher; Grünwald, Viktor; Tschirdewahn, Stephan; Hadaschik, Boris; Horvath, Orsolya; Kenessey, Istvan; Nyirady, Peter; Varadi, Melinda; Modos, Orsolya; Csizmarik, Anita; Szarvas, Tibor
    High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapy
    In: Cancers Jg. 13 (2021) Nr. 11, 2548
  • Schaudinn, Alexander; Michaelis, Jakob; Franz, Toni; Ho-Thi, Phuc; Horn, Lars-Christian; Blana, Andreas; Hadaschik, Boris; Stumpp, Patrick; Stolzenburg, Jens-Uwe; Schlemmer, Heinz–Peter; Denecke, Timm; Busse, Harald; Ganzer, Roman; Linder, Nicolas
    High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients
    In: European Journal of Radiology Jg. 144 (2021) 109957
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Herrmann, Ken; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Fendler, Wolfgang
    Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 5, S. 675 - 678
  • Berrens, Anne-Claire; van Leeuwen, Pim J.; Maurer, Tobias; Hadaschik, Boris; Krafft, Ulrich
    Implementation of radioguided surgery in prostate cancer
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 65 (2021) Nr. 3, S. 202 - 214
  • Handke, Analena Elisa; Graefen, Markus; Ullrich, Tim; Wibmer, Andreas; Hadaschik, Boris; Giganti, Francesco; Schimmöller, Lars; Radtke, Jan Philipp
    Kann die Progression eines Prostatakarzinoms während Active Surveillance durch serielle Magnetresonanztomographie verlässlich diagnostiziert werden?
    In: Der Urologe Jg. 60 (2021) Nr. 12, S. 1594 - 1597
  • Stuschke, Martin; Hadaschik, Boris
    Lokale Strahlentherapie der Prostata mit Samenblasenbasis allein oder mit elektiver Bestrahlung pelviner Lymphknotenstationen beim Hochrisiko-Prostatakarzinom? : Ergebnisse der randomisierten POP-RT-Studie
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. 10, S. 939 - 942
  • Püllen, Lukas; Sprave, Tanja; Hadaschik, Boris; Wiegel, Thomas
    Lokale und Metastasen-gerichtete Therapieoptionen beim oligometastasierten Prostatakarzinom
    In: Aktuelle Urologie Jg. 52 (2021) Nr. 2, S. 149 - 154
  • Heß-Busch, Yasmine; Hadaschik, Boris; Heß, Jochen A.
    M0CRPC overview of management options
    In: World Journal of Urology Jg. 39 (2021) Nr. 2, S. 349 - 356
  • Szarvas, Tibor; Hoffmann, Michèle J.; Olah, Csilla; Szekely, Eszter; Kiss, Andras; Hess, Jochen; Tschirdewahn, Stephan; Hadaschik, Boris; Grotheer, Vera; Nyirady, Peter; Csizmarik, Anita; Varadi, Melinda; Reis, Henning
    MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
    In: Diagnostics Jg. 11 (2021) Nr. 1, 48
  • Csizmarik, Anita; Hadaschik, Boris; Kramer, Gero; Nyirady, Peter; Szarvas, Tibor
    Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 10, S. 728.e13 - 728.e24
  • Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R.; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R.; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B.; Delpassand, Ebrahim S.; Haberkorn, Uwe; Elashoff, David; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective study
    In: The Lancet Oncology Jg. 22 (2021) Nr. 8, S. 1115 - 1125
  • Herrmann, Ken; Kraus, Bernd Joachim; Hadaschik, Boris; Kunikowska, Jolanta; van Poppel, Hendrik; N'Dow, James; Sartor, Oliver; Oyen, Wim J. G.
    Nuclear medicine theranostics comes of age
    In: The Lancet Oncology Jg. 22 (2021) Nr. 11, S. 1497 - 1498
  • Seifert, Robert; Kessel, Katharina; Schlack, Katrin; Weber, Manuel; Herrmann, Ken; Spanke, Maximilian; Fendler, Wolfgang; Hadaschik, Boris; Kleesiek, Jens; Schäfers, Michael; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz
    PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 4, S. 1200 - 1210
  • Barbato, Francesco; Fendler, Wolfgang; Rauscher, Isabel; Herrmann, Ken; Wetter, Axel; Ferdinandus, Justin; Seifert, Robert; Nader, Michael; Rahbar, Kambiz; Hadaschik, Boris; Eiber, Matthias; Gafita, Andrei; Weber, Manuel
    PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1747 - 1750
  • Weber, Manuel; Kurek, Claudia Ewa; Barbato, Francesco; Eiber, Matthias; Maurer, Tobias; Nader, Michael; Hadaschik, Boris; Grünwald, Viktor; Herrmann, Ken; Wetter, Axel; Fendler, Wolfgang Peter
    PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center study
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 88 - 91
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang P.
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocol
    In: BMC Cancer Jg. 21 (2021) 512
  • Farolfi, Andrea; Hadaschik, Boris; Hamdy, Freddie C.; Herrmann, Ken; Hofman, Michael S.; Murphy, Declan G.; Ost, Piet; Padhani, Anwar R.; Fanti, Stefano
    Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic Review
    In: European Urology Oncology Jg. 4 (2021) Nr. 5, S. 714 - 730
  • Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan
    Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls
    In: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985
  • Hadaschik, Boris; Giesel, Frederik L.; Chi, Kim
    Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
    In: European Urology Focus Jg. 7 (2021) Nr. 2, S. 229 - 230
  • Weber, Manuel; Hadaschik, Boris; Ferdinandus, Justin; Rahbar, Kambiz; Bögemann, Martin; Herrmann, Ken; Fendler, Wolfgang; Kesch, Claudia
    Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate Cancer
    In: European Urology Focus Jg. 7 (2021) Nr. 2, S. 279 - 287
  • Hadaschik, Boris; Herrmann, Ken
    Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    In: European Urology Jg. 80 (2021) Nr. 4, S. 520 - 521
  • Grünwald, Viktor; Hadaschik, Boris
    Re: Nivolumab plus Cabozantinib Versus Sunitinib for Advanced Renal-cell Carcinoma
    In: European Urology Jg. 80 (2021) Nr. 2, S. 256 - 257
  • Radtke, Jan Philipp; Nyarangi-Dix, Joanne; Wiesenfarth, Manuel; Hadaschik, Boris
    Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy
    In: European Urology Jg. 79 (2021) Nr. 1, S. 164 - 165
  • Harke, Nina; Darr, Christopher; Radtke, Jan Philipp; von Ostau (N.), Nicola; Schiefelbein, Frank; Eraky, Ahmed; Hamann, Claudius; Szarvas, Tibor; Hadaschik, Boris; Tropmann-Frick, Marina; Juenemann, Klaus-Peter; Schoen, Georg; Osmonov, Daniar
    Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy : A Multicenter Matched-pair Analysis
    In: European Urology Focus Jg. 7 (2021) Nr. 6, S. 1363 - 1370
  • Rehme, Christian R.; Burchert, Carolin; Tosun, Mustafa; Szarvas, Tibor; Nagy, Nadine; Rübben (H.), Herbert; Hadaschik, Boris; Niedworok, Christian
    Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patients
    In: Translational Andrology and Urology Jg. 10 (2021) Nr. 1, S. 87 - 95
  • Harke, Nina Natascha; Wagner, Christian; Liakos, Nikolaos; Urbanova, Katarina; Addali, Mustapha; Hadaschik, Boris; Witt, Jorn H.
    Superior early and long-term continence following early micturition on day 2 after robot-assisted radical prostatectomy : A randomized prospective trial
    In: World Journal of Urology Jg. 39 (2021) Nr. 3, S. 771 - 777
  • Panic, Andrej; Reis, Henning; Wittka, Alina; Darr, Christopher; Hadaschik, Boris; Jendrossek, Verena; Klein, Diana
    The Biomarker Potential of Caveolin-1 in Penile Cancer
    In: Frontiers in Oncology Jg. 11 (2021) S. 606122
  • Szarvas, Tibor; Csizmarik, Anita; Váradi, M.; Fazekas, Tamás; Hüttl, András Béla; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Tschirdewahn, Stephan; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnes B.; Kramer, Gero
    The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy
    In: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 5, S. 296.e11 - 296.e19
  • Hirner, Lucas; Rübben, Iris; Lax, H.; Hirner, C.; Panic, Andrej; Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Niedworok, Christian; Rehme, Christian R.
    The value of an additional scrotal suture during orchidopexy
    In: Journal of Pediatric Urology Jg. 17 (2021) Nr. 1, S. 82.e1 - 82.e5
  • Hadaschik, Boris; Hellmis, Eva
    Therapie des nicht-fernmetastasierten CRPC : Androgenrezeptorinhibition als neuer Therapiestandard beim nicht-fernmetastasierten kastrationsresistenten Prostatakarzinom mit hohem Metastasierungsrisiko
    In: Der Urologe Jg. 60 (2021) Nr. 6, S. 753 - 759
  • Panic, Andrej; Rahmani, N.; Kaspar, Cordelia; Radtke, J.P.; Darr, C.; Henkel, Alexander; Hadaschik, Boris; Tschirdewahn, Stephan; Hess, J.
    Transrectal Ultrasound Guided Hydrodistension : A New Surgical Way in Transgender Surgery
    In: The Journal of Sexual Medicine Jg. 18 (2021) Nr. 6, S. 1134 - 1140
  • Kaspar, Cordelia; Reis, Henning; Stehling, Florian; Dirksen, Uta; Hadaschik, Boris; Rehme, Christian R.
    Zystisches Nephrom bei einem 15 Monate alten Patienten mit DICER1-Mutation
    In: Der Urologe Jg. 60 (2021) Nr. 6, S. 776 - 779
  • Eisenhardt, Andreas; Schneider, Katharina; Hirche, Herbert; Lax, Hildegard; Hadaschik, Boris; Rehme, Christian R.; Van Gool, Jan D.
    Diagnosis and Empirical Treatment of Urinary Tract Infections in Urologic Outpatients
    In: Urologia Internationalis Jg. 104 (2020) Nr. 7-8, S. 617 - 624
  • Radtke, Jan Philipp; Hadaschik, Boris
    Editorial Comment : [zu Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy]
    In: The Journal of Urology Jg. 204 (2020) Nr. 3, S. 510
  • Püllen, Lukas; Radtke, Jan P.; Wiesenfarth, Manuel; Roobol, Monique J.; Verbeek, Jan F.M.; Wetter, Axel; Guberina, Nika; Pandey, Abhishek; Hüttenbrink, Clemens; Tschirdewahn, Stephan; Pahernik, Sascha; Hadaschik, Boris; Distler, Florian A.
    External validation of novel magnetic resonance imaging-based models for prostate cancer prediction
    In: BJU International (BJUI) Jg. 125 (2020) Nr. 3, S. 407 - 416
  • Darr, Christopher; Krafft, Ulrich; Fendler, W.P.; Costa, P. Fragoso; Barbato, F.; Praus, C.; Reis, Henning; Hager, T.; Tschirdewahn, Stephan; Radtke, J.P.; Herrmann, Ken; Hadaschik, Boris
    First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3194 - 3195
  • Darr, Christopher; Harke, Nina; Radtke, Jan Philipp; Yirga, Leubet; Kesch, Claudia; Grootendorst, Maarten; Fendler, Wolfgang; Fragoso Costa, Pedro; Rischpler, Christoph; Praus, Christine; Haubold, Johannes; Reis, Henning; Hager, Thomas; Herrmann, Ken; Binse, Ina; Hadaschik, Boris
    Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility study
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 10, S. 1500 - 1506
  • Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Calais, Jeremie; Barbato, Francesco; Weber, Manuel; Afshar-Oromieh, Ali; Spohn, Fabian; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang Peter
    Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 7, S. 1037 - 1042
  • Chowdhury, Simon; Oudard, Stéphane; Uemura, Hiroji; Joniau, Steven; Pilon, Dominic; Lefebvre, Patrick; McQuarrie, Kelly; Liu, Jinan; Dearden, Lindsay; Sermon, Jan; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris
    Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
    In: Advances in Therapy Jg. 37 (2020) Nr. 1, S. 512 - 526
  • Chowdhury, Simon; Oudard, Stéphane; Uemura, Hiroji; Joniau, Steven; Pilon, Dominic; Ladouceur, Martin; Behl, Ajay S.; Liu, Jinan; Dearden, Lindsay; Sermon, Jan; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris
    Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
    In: Advances in Therapy Jg. 37 (2020) S. 501 - 511
  • Ohlmann, Carsten H.; Hadaschik, Boris
    Minimalinvasive Chirurgie aggressiver Tumoren
    In: Der Urologe (2020)
  • Tschirdewahn, Stephan; Harke, Nina; Hirner, Lucas; Stagge, E.; Hadaschik, Boris; Eisenhardt, Andreas
    Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder : a randomized study in comparison with white light cystoscopy
    In: World Journal of Urology Jg. 38 (2020) Nr. 6, S. 1509 - 1515
  • Krafft, Ulrich; Reis, Henning; Ingenwerth, Marc; Kovalszky, Ilona; Becker, Markus; Niedworok, Christian; Darr, Christopher; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 1, S. 253 - 261
  • Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Módos, Orsolya; Szendrői, Attila; Bíró, Krisztina; Hager, Thomas; Herold, Thomas; Ablat, Jason; Black, Peter C.; Okon, Krzysztof; Tolkach, Yuri; Csizmarik, Anita; Oláh, Csilla; Keresztes, David; Bremmer, Felix; Gaisa, Nadine T.; Kriegsmann, Joerg; Kovalszky, Ilona; Kiss, András; Tímár, József; Szász, Marcell A.; Rink, Michael; Fisch, Margit; Nyirády, Péter; Szarvas, Tibor
    Prevalence of APC and PTEN Alterations in Urachal Cancer
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 4, S. 2773 - 2781
  • Ferdinandus, Justin; Fendler, Wolfgang Peter; Hadaschik, Boris; Herrmann, Ken
    Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence
    In: Current Opinion in Urology Jg. 30 (2020) Nr. 5, S. 635 - 640
  • Radtke, Jan Philipp; Hadaschik, Boris
    Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
    In: European Urology Jg. 78 (2020) Nr. 2, S. 291 - 292
  • Hadaschik, Boris; Herrmann, Ken
    Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre Study
    In: European Urology Jg. 78 (2020) Nr. 3, S. 470 - 471
  • Darr, C.; Krafft, Ulrich; Panic, Andrej; Tschirdewahn, Stephan; Hadaschik, Boris; Rehme, Christian R.
    Renal duplication with ureter duplex not following Meyer-Weigert-Rule with development of a megaureter of the lower ureteral segment due to distal stenosis – A case report
    In: Urology Case Reports Jg. 28 (2020) 101038
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina; Hadaschik, Boris; Nyirády, Péter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Olah, Csilla; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
    In: Pathology & Oncology Research Jg. 26 (2020) Nr. 2, S. 1243 - 1249
  • Niedworok, Christian; Kempkensteffen, Carsten; Eisenhardt, Andreas; Tschirdewahn, Stephan; Rehme, Christian R.; Panic, Andrej; Reis, Henning; Baba, Hideo Andreas; Nyirády, Peter; Hadaschik, Boris; Kovalszky, Ilona; Szarvas, Tibor
    Serum and tissue syndecan-1 levels in renal cell carcinoma
    In: Translational Andrology and Urology Jg. 9 (2020) Nr. 3, S. 1167 - 1176
  • Olah, Csilla; Tschirdewahn, Stephan; Hoffmann, Michèle J.; Krafft, Ulrich; Hadaschik, Boris; Nyirady, Peter; Szendröi, Attila; Módos, Orsolya; Csizmarik, Anita; Kovalszky, Ilona; Reis, Henning; Szarvas, Tibor
    Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patients
    In: Diagnostics Jg. 10 (2020) Nr. 11, 864
  • Knipper, S.; Graefen, M.; Hadaschik, Boris; Wiegel, T.
    Therapiekonzepte beim primär oligometastasierten Prostatakarzinom
    In: Der Urologe Jg. 59 (2020) Nr. 6, S. 659 - 664
  • Harke, Nina; Radtke, Jan P.; Hadaschik, Boris; Bach, Christian; Berger, Frank P.; Blana, Andreas; Borgmann, Hendrik; Distler, Florian A.; Edeling, Sebastian; Egner, Tobias; Engels, Christina L.; Farzat, Mahmoud; Haese, Alexander; Hein, Rainer; Kuczyk, Markus A.; Manseck, Andreas; Moritz, Rudolf; Musch, Michael; Peters, Inga; Pokupic, Sasa; Rocco, Bernardo; Schneider, Andreas; Schumann, André; Schwentner, Christian; Sighinolfi, Chiara M.; Buse, Stephan; Stolzenburg, Jens-Uwe; Truß, Michael C.; Waldner, Michael; Wülfing, Christian; Zimmermanns, Volker; Witt, Jörn H.; Wagner, Christian
    To defer or not to defer? : A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic
    In: PLoS ONE Jg. 15 (2020) Nr. 9, S. e0239027
  • Hager, Thomas; Kraywinkel, Klaus; Szarvas, Tibor; Hadaschik, Boris; Schmid, Kurt Werner; Reis, Henning
    Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison study
    In: Urologia Internationalis Jg. 104 (2020) Nr. 9-10, S. 803 - 809
  • Kasper, Stefan; Virchow, Isabel; Hadaschik, Boris; Radtke, Jan Philipp
    Was erwartet der Nichtradiologe vom Radiologen?
    In: Der Radiologe Jg. 60 (2020) Nr. 5, S. 421 - 429
  • Guberina, Nika; Hetkamp, Philipp; Rübben, Herbert; Fendler, W.; Grueneisen, J.; Suntharalingam, S.; Kirchner, J.; Püllen, Lukas; Harke, Nina; Radtke, J.P.; Umutlu, Lale; Hadaschik, Boris; Herrmann, Ken; Forsting, Michael; Wetter, Axel
    Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of Reference
    In: Molecular Imaging and Biology Jg. 22 (2020) Nr. 3, S. 788 - 796
  • Grummet, Jeremy; Gorin, Michael A.; Popert, Rick; O’Brien, Tim; Lamb, Alastair D.; Hadaschik, Boris; Radtke, Jan Philipp; Wagenlehner, Florian; Baco, Eduard; Moore, Caroline M.; Emberton, Mark; George, Arvin K.; Davis, John W.; Szabo, Richard J.; Buckley, Roger; Loblaw, Andrew; Allaway, Matthew; Kastner, Christof; Briers, Erik; Royce, Peter L.; Frydenberg, Mark; Murphy, Declan G.; Woo, Henry H.
    “TREXIT 2020” : Why the time to abandon transrectal prostate biopsy starts now
    In: Prostate Cancer and Prostatic Diseases Jg. 23 (2020) Nr. 1, S. 62 - 65
  • De Visschere, Pieter J.L.; Standaert, Chloë; Fütterer, Jurgen J.; Villeirs, Geert M.; Panebianco, Valeria; Walz, Jochen; Maurer, Tobias; Hadaschik, Boris; Lecouvet, Frédéric E.; Giannarini, Gianluca; Fanti, Stefano
    A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
    In: European Urology Oncology Jg. 2 (2019) Nr. 1, S. 47 - 76
  • Leyh-Bannurah, Sami-Ramzi; Cash, Hannes; Borkowetz, Angelika; Graefen, Markus; Schlomm, Thorsten; Hadaschik, Boris; Budäus, Lars
    Active Surveillance und die moderne Diagnostik des Prostatatkarzinoms : Multiparametrische MRT, Fusionsbiopsien und neue genetische Biomarker
    In: Der Onkologe Jg. 25 (2019) Nr. 4, S. 304 - 314
  • Small, Eric J.; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie; Olmos, David; Mainwaring, Paul; Lee, J.Y.; Uemura, Hiroshi; De Porre, Peter; Smith, Ariane; Zhang, Ke; Lopez-Gitlitz, Angela; Smith, Matthew R.
    Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
    In: Annals of Oncology Jg. 30 (2019) Nr. 11, S. 1813 - 1820
  • Tschirdewahn, Stephan; Panic, Andrej; Püllen, Lukas; Harke, Nina; Hadaschik, Boris; Riesz, Peter; Horváth, Andras; Szalontai, Janos; Nyirády, Peter; Baba, Hideo Andreas; Reis, Henning; Szarvas, Tibor
    Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma
    In: International Journal of Cancer Jg. 145 (2019) Nr. 2, S. 531 - 539
  • Reis, Henning; Mairinger, F.; Ting, Saskia; Nagy, N.; Witzke, K.E.; Kohl, M.; Sitek, B.; Niedworok, Christian; Hadaschik, Boris; Nyirády, P.; Szarvas, Tibor
    Das Urachuskarzinom : Ein Update aktueller molekularer Ergebnisse
    In: Der Pathologe Jg. 40 (2019) Nr. Suppl. 3, S. 239 - 243
  • Püllen, Lukas; Hadaschik, Boris; Eberli, D.; Kuru, T. H.
    Die Fusionsbiopsie in der Primärdiagnostik des Prostatakarzinoms : Durchführung, Nutzen und klinische Aspekte
    In: Der Urologe Jg. 58 (2019) Nr. 5, S. 504 - 510
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Londhe, Anil; Bhaumik, Amitabha; Cheng, Shinta; Rooney, Oliver Brendan; Smith, Matthew Raymond
    Efficacy of apalutamide (APA) plus ongoing androgen deprivation therapy (ADT) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) and baseline (BL) comorbidities (CM)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15_Suppl, S. 5023 - 5023
  • Kesch, Claudia; Hadaschik, Boris
    Ein neuer Androgenrezeptorantagonist : Darolutamid für Patienten mit nicht fernmetastasiertem, kastrationsresistentem Prostatakarzinom
    In: Der Urologe Jg. 58 (2019) Nr. 10, S. 1217 - 1218
  • Hallanzy, Jacqueline; Kron, Martina; Goethe, Veronika E.; Köhn, Frank-Michael; Schmautz, Maximilian; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen E.; Herkommer, Kathleen
    Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities : Results From the German Male Sex Study
    In: Sexual Medicine Jg. 7 (2019) Nr. 1, S. 26 - 34
  • Meissner, Valentin H.; Schroeter, Lukas; Köhn, Frank-Michael; Kron, Martina; Zitzmann, Michael; Arsov, Christian; Imkamp, Florian; Hadaschik, Boris; Gschwend, Jürgen E.; Herkommer, Kathleen
    Factors Associated with Low Sexual Desire in 45-Year-Old Men : Findings from the German Male Sex-Study
    In: The Journal of Sexual Medicine Jg. 16 (2019) Nr. 7, S. 981 - 991
  • Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Eiber, Matthias; Afshar-Oromieh, Ali; Spohn, Fabian; Barbato, Francesco; Weber, Manuel; Ilhan, Harun; Cervati, Veronica; Wetter, Axel; Hadaschik, Boris; Briganti, Alberto; Walz, Jochen; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken; Fendler, Wolfgang Peter
    Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study
    In: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1174 - 1181
  • Szarvas, Tibor; Jardin-Watelet, Bénédicte; Bourgoin, Nicolas; Hoffmann, Michèle J; Nyirady, Peter; Oláh, Csilla; Széll, Tamás; Csizmarik, Anita; Hadaschik, Boris; Reis, Henning
    High soluble CGA levels are associated with poor survival in bladder cancer
    In: Endocrine Connections Jg. 8 (2019) Nr. 5, S. 625 - 633
  • Feng, Felix Y; Thomas, Shibu; Gormley, Michael; Lopez-Gitlitz, Angela; Yu, Margaret K.; Cheng, Shinta; Ricci, Deborah S.; Rooney, Oliver Brendan; Mainwaring, Paul N.; Olmos, David; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris; Fishbane, Nicholas; Davicioni, Elai; Liu, Yang; Small, Eric Jay; Smith, Matthew Raymond
    Identifying molecular determinants of response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the SPARTAN trial.
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 7_Suppl, S. 42 - 42
  • Pomykala, Kelsey L.; Farolfi, Andrea; Hadaschik, Boris; Fendler, Wolfgang P.; Herrmann, Ken
    Molecular Imaging for Primary Staging of Prostate Cancer
    In: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 4, S. 271 - 279
  • Taplin, Mary-Ellen; Gleave, Martin; Evans, Christopher P.; Efstathiou, Eleni; Kantoff, Philip W.; Ross, Ashley; Shore, Neal D.; Briganti, Alberto; Hadaschik, Boris; Heidenreich, Axel; Rooney, Oliver Brendan; Tian, Shaozhou Ken; Wetherhold, Lisa; Xu, Weichun; Cheng, Shinta; Kibel, Adam S.
    PROTEUS : A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15_Suppl, S. TPS5100 - TPS5100
  • Maurer, Tobias; Hadaschik, Boris; Budäus, Lars Henrik; Steuber, Thomas; Salomon, Georg; Horn, Thomas; Herrmann, Ken; Weber, Manuel; Giesel, Frederik Lars; Berliner, C.; Eiber, Matthias J.
    PSA-Anstieg nach definitiver Therapie
    In: Der Urologe Jg. 58 (2019) Nr. 5, S. 569 - 582
  • Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris
    Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer
    In: Clinical Cancer Research Jg. 25 (2019) Nr. 24, S. 7448 - 7454
  • Breidenstein, Anja; Heß, Jochen A.; Hadaschik, Boris; Teufel, Martin; Tagay, Sefik
    Psychosocial Resources and Quality of Life in Transgender Women following Gender-Affirming Surgery
    In: The Journal of Sexual Medicine Jg. 16 (2019) Nr. 10, S. 1672 - 1680
  • Hadaschik, Boris; Ost, Piet
    Re: Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical Trial
    In: European Urology Jg. 76 (2019) Nr. 4, S. 538 - 539
  • Hallanzy, Jacqueline; Kron, Martina; Goethe, Veronika E.; Köhn, Frank Michael; Schmautz, Maximilian; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen Erich; Herkommer, Kathleen
    Re: Erectile dysfunction in 45-year-old heterosexual German men and associated lifestyle risk factors and comorbidities : Results from the German Male sex study
    In: The Journal of Urology Jg. 202 (2019) Nr. 4, S. 644
  • Ohlmann, Carsten-Henning; Hadaschik, Boris
    Re: Minimally Invasive Versus Abdominal Radical Hysterectomy for Cervical Cancer
    In: European Urology Jg. 75 (2019) Nr. 5, S. 875
  • Grünwald, Viktor; Hadaschik, Boris
    Re: Preliminary Results for Avelumab Plus Axitinib as First-Line Therapy in Patients with Advanced Clear-cell Renal-cell Carcinoma (JAVELIN Renal 100) : An Open-label, Dose-finding and Dose-expansion, Phase 1b Trial
    In: European Urology Jg. 75 (2019) Nr. 4, S. 697 - 698
  • Darr, C.; Hadaschik, Boris; Tschirdewahn, Stephan
    Systemtherapie des metastasierten Tumors des oberen Harntraktes
    In: Der Urologe Jg. 58 (2019) Nr. 1, S. 30 - 33
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Espina, Byron M.; Shu, Youyi; Rackoff, Wayne R.; Rooney, Oliver Brendan; Londhe, Anil; Cheng, Shinta; Smith, Matthew Raymond
    Updated analysis of progression-free survival with first subsequent therapy (PFS2) and safety in the SPARTAN study of apalutamide (APA) in patients (pts) with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC).
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 7_Suppl, S. 144 - 144
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina N.; Hadaschik, Boris; Olah, Csilla; Krege, Susanne; Nyirády, Peter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 37 (2019) Nr. 11, S. 810.e7 - 810.e15
  • Sachpekidis, Christos; Pan, Leyun; Hadaschik, Boris; Kopka, Klaus; Haberkorn, Uwe; Dimitrakopoulou-Strauss, Antonia
    68Ga-PSMA-11 PET/CT in prostate cancer local recurrence : impact of early images and parametric analysis
    In: American Journal of Nuclear Medicine and Molecular Imaging Jg. 8 (2018) Nr. 5, S. 351 - 359
  • Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Graff, Julie N.; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Trudel, Géralyn C.; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.; Small, Eric J.
    Apalutamide treatment and metastasis-free survival in prostate cancer
    In: The New England Journal of Medicine Jg. 378 (2018) Nr. 15, S. 1408 - 1418
  • Harke, Nina; Mandel, Philipp; Witt, Jorn H.; Wagner, Christian; Panic, Andrej; Boy, Anselm; Roosen, Alexander; Ubrig, Burkhard; Schneller, Andreas; Schiefelbein, Frank; Wagener, Nina; Honeck, Patrick; Schoen, Georg; Hadaschik, Boris; Michel, Maurice S.; Kriegmair, Maximilian C.
    Are there limits of robotic partial nephrectomy? : TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumors
    In: Journal of Surgical Oncology Jg. 118 (2018) Nr. 1, S. 206 - 211
  • Reis, Henning; Krafft, Ulrich; Niedworok, Christian; Módos, Orsolya; Herold, Thomas; Behrendt, Mark; Al-Ahmadie, Hikmat; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
    Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own Data
    In: Disease Markers (2018) 7308168
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, Henning; Hadaschik, Boris; Shariat, Shahrokh F.; Kramer, Gero
    Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations Jg. 36 (2018) Nr. 6, S. 312.e9 - 312.e15
  • Lang, Stephan; Bruderek, Kirsten; Kaspar, Cordelia; Höing, Benedikt; Kanaan, Oliver; Dominas, Nina; Hussain, Timon; Droege, Freya; Eyth, Christian; Hadaschik, Boris; Brandau, Sven
    Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
    In: Clinical Cancer Research Jg. 24 (2018) Nr. 19, S. 4834 - 4844
  • Goethe, Veronika E.; Angerer, Hannes; Dinkel, Andreas; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen E.; Herkommer, Kathleen
    Concordance and Discordance of Sexual Identity, Sexual Experience, and Current Sexual Behavior in 45-Year-Old Men : Results From the German Male Sex-Study
    In: Sexual Medicine Jg. 6 (2018) Nr. 4, S. 282 - 290
  • Kesch, Claudia; Radtke, Jan-Philipp; Wintsche, Axel; Wiesenfarth, Manuel; Luttje, Mariska; Gasch, Claudia; Dieffenbacher, Svenja; Pecqueux, Carine; Teber, Dogu; Hatiboglu, Gencay; Nyarangi-Dix, Joanne; Simpfendörfer, Tobias; Schönberg, Gita; Dimitrakopoulou-Strauss, Antonia; Freitag, Martin; Duensing, Anette; Grüllich, Carsten; Jäger, Dirk; Götz, Michael; Grabe, Niels; Schweiger, Michal-Ruth; Pahernik, Sascha; Perner, Sven; Herpel, Esther; Roth, Wilfried; Wieczorek, Kathrin; Maier-Hein, Klaus; Debus, Jürgen; Haberkorn, Uwe; Giesel, Frederik; Galle, Jörg; Hadaschik, Boris; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Bonekamp, David; Sültmann, Holger; Duensing, Stefan
    Correlation between genomic index lesions and mpMRI and ⁶⁸Ga-PSMA-PET/CT imaging features in primary prostate cancer
    In: Scientific Reports Jg. 8 (2018) Nr. 1, S. 16708
  • Boegemann, Martin; Arsov, Christian; Hadaschik, Boris; Herkommer, Kathleen; Imkamp, Florian; Nofer, Jerzy-Roch; Gerß, Joachim; Albers, Peter; Semjonow, Axel
    Discordant prostate specific antigen test results despite WHO assay standardization
    In: The International Journal of Biological Markers (IJBM) Jg. 33 (2018) Nr. 3, S. 275 - 282
  • Saad, Fred; Cella, David; Basch, Ethan; Hadaschik, Boris; Mainwaring, Paul N.; Oudard, Stéphane; Graff, Julie N.; McQuarrie, Kelly; Li, Susan; Hudgens, Stacie; Lawson, Joe; Lopez-Gitlitz, Angela; Yu, Margaret K.; Smith, Matthew R.; Small, Eric J.
    Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
    In: The Lancet Oncology Jg. 19 (2018) Nr. 10, S. 1404 - 1416
  • Harke, Nina Natascha; Godes, Michael; Wagner, Christian; Addali, Mustapha; Fangmeyer, Bernhard; Urbanova, Katarina; Hadaschik, Boris; Witt, Jorn H.
    Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy : a prospective, randomized trial
    In: World Journal of Urology Jg. 36 (2018) Nr. 11, S. 1817 - 1823
  • Warsow, Gregor; Hübschmann, Daniel; Kleinheinz, Kortine; Nientiedt, Cathleen; Heller, Martina; Van Coile, Laura; Tolstov, Yanis; Trennheuser, Lukas; Wieczorek, Kathrin; Pecqueux, Carine; Gasch, Claudia; Kuru, Timur; Nyarangi-Dix, Joanne; Hatiboglu, Gencay; Teber, Dogu; Perner, Sven; Stenzinger, Albrecht; Roth, Wilfried; Hadaschik, Boris; Pahernik, Sascha; Jäger, Dirk; Grüllich, Carsten; Duensing, Anette; Eils, Roland; Schlesner, Matthias; Sültmann, Holger; Hohenfellner, Markus; Duensing, Stefan
    Genomic features of renal cell carcinoma with venous tumor thrombus
    In: Scientific Reports Jg. 8 (2018) Nr. 1, S. 7477
  • Afshar-Oromieh, Ali; Debus, Nils; Uhrig, Monika; Hope, Thomas A.; Evans, Michael J.; Holland-Letz, Tim; Giesel, Frederik L.; Kopka, Klaus; Hadaschik, Boris; Kratochwil, Clemens; Haberkorn, Uwe
    Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 12, S. 2045 - 2054
  • Kasivisvanathan, Veeru; Rannikko, Antti S.Sakari; Borghi, Marcelo; Panebianco, Valeria; Mynderse, Lance A.; Vaarala, Markku H.; Briganti, Alberto; Budäus, Lars Henrik; Hellawell, Giles O.; Hindley, Richard Graham; Roobol, Monique J.; Eggener, Scott E.; Ghei, Maneesh; Villers, Arnauld A.; Bladou, Franck; Villeirs, Geert M.; Virdi, Jaspal S.; Boxler, Silvan; Robert, Grégoire Y.; Singh, Paras B.; Venderink, Wulphert; Hadaschik, Boris; Ruffion, Alain; Hu, Jim C.; Margolis, Daniel Jason Aaron; Crouzet, Sébastien; Klotz, Laurence H.; Taneja, Samir S.; Pinto, Peter A.; Gill, Inderbir S.; Allen, Clare M.; Giganti, Francesco; Freeman, Alex A.; Morris, Stephen J.; Punwani, Shonit; Williams, Norman R.; Brew-Graves, Chris; Deeks, Jonathan J.; Takwoingi, Yemisi; Émberton, Mark E.; Moore, Caroline M.; F.R.C.S.(Urol.) for the PRECISION Study Group Collaborators
    MRI-targeted or standard biopsy for prostate-cancer diagnosis
    In: The New England Journal of Medicine Jg. 378 (2018) Nr. 19, S. 1767 - 1777
  • Chowdhury, S.; Oudard, S.; Hadaschik, Boris; Uemura, H.; Joniau, S.; Pilon, D.; Ladouceur, M.; Behl, A.; Liu, J.; Dearden, L.; Sermon, J.; Van Sanden, S.; Diels, J.
    Matching-adjusted indirect comparison of the effiacy of apalutamide and enzalutamide in the treatment of non-metastatic castration-resistant prostate cancer
    In: Value in Health Jg. 21 (2018) Nr. Suppl. 3, S. 20 - S21
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Csizmarik, Anita; Ristl, Robin; Puhr, Martin; Hoffmann, Michèle J.; Niedworok, Christian; Hadaschik, Boris; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero
    Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
    In: BJU International (BJUI) Jg. 122 (2018) Nr. 4, S. 695 - 704
  • Hansen, Nienke L.; Barrett, Tristan; Kesch, Claudia; Pepdjonovic, Lana; Bonekamp, David; O'Sullivan, Richard; Distler, Florian; Warren, Anne; Samel, Christina; Hadaschik, Boris; Grummet, Jeremy; Kastner, Christof
    Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer
    In: BJU International (BJUI) Jg. 122 (2018) Nr. 1, S. 40 - 49
  • Kesch, Claudia; Schütz, Viktoria; Dieffenbacher, Svenja; Bonekamp, David; Hadaschik, Boris; Hohenfellner, Markus; Radtke, Jan P.
    Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer
    In: Current Opinion in Urology Jg. 28 (2018) Nr. 2, S. 172 - 177
  • Hadaschik, Boris; Panic, Andrej
    Neue Therapieoption : Apalutamid beim nicht fernmetastasierten kastrationsresistenten Prostatakarzinom
    In: Der Urologe Jg. 57 (2018) Nr. 6, S. 729 - 730
  • Baranski, Ann-Christin; Schäfer, Martin; Bauder-Wüst, Ulrike; Roscher, Mareike; Schmidt, Jana; Stenau, Esther; Simpfendörfer, Tobias; Teber, Dogu; Maier-Hein, Lena; Hadaschik, Boris; Haberkorn, Uwe; Eder, Matthias; Kopka, Klaus
    PSMA-11–Derived dual-Labeled PSMA inhibitors for preoperative PET imaging and precise fluorescence-Guided surgery of prostate cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 4, S. 639 - 645
  • Hadaschik, Boris
    Paradigmenwechsel in der Urologie : Prostatakrebsdiagnostik mittels MRT-gezielter oder konventioneller transrektaler ultraschallgesteuerter Biopsie
    In: Der Urologe Jg. 57 (2018) Nr. 6, S. 727 - 728
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773
  • Ganzer, Roman; Hadaschik, Boris; Pahernik, Sascha; Koch, Daniel; Baumunk, Daniel; Kuru, Timur; Heidenreich, Axel; Stolzenburg, Jens-Uwe; Schostak, Martin; Blana, Andreas
    Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound
    In: The Journal of Urology Jg. 199 (2018) Nr. 4, S. 983 - 989
  • Borkowetz, Angelika; Hadaschik, Boris; Platzek, Ivan; Toma, Marieta; Torsev, Georgi; Renner, Theresa; Herout, Roman; Baunacke, Martin; Laniado, Michael; Baretton, Gustavo; Radtke, Jan Philipp; Kesch, Claudia; Hohenfellner, Markus; Froehner, Michael; Schlemmer, Heinz-Peter; Wirth, Manfred; Zastrow, Stefan
    Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients
    In: BJOG: formerly: The Journal of Obstetrics and Gynaecology of the British Commonwealth / of the British Empire; British Journal of Obstetrics and Gynaecology Jg. 121 (2018) Nr. 1, S. 53 - 60
  • Eiber, Matthias; Herrmann, Ken; Calais, Jeremie; Hadaschik, Boris; Giesel, Frederik L.; Hartenbach, Markus; Hope, Thomas; Reiter, Robert; Maurer, Tobias; Weber, Wolfgang A.; Fendler, Wolfgang P.
    Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CT
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 469 - 478
  • Heß, Jochen A.; Henkel, Alexander; Bohr, Julia; Rehme, Christian R.; Panic, Andrej; Panic, Leo; Rossi Neto, R.; Hadaschik, Boris; Heß, Yasmine
    Sexuality after Male-to-Female Gender Affirmation Surgery
    In: BioMed Research International (2018) 9037979
  • Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Tschirdewahn, Stephan; Sevcenco, Sabina; Csizmarik, Anita; Nyirady, Peter; Küronya, Zsófia; Reis, Henning; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero; Szarvas, Tibor
    The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
    In: Urologia Internationalis Jg. 101 (2018) Nr. 1, S. 65 - 73
  • Sachpekidis, Christos; Bäumer, P.; Kopka, K.; Hadaschik, Boris; Hohenfellner, M.; Kopp-Schneider, A.; Haberkorn, U.; Dimitrakopoulou-Strauss, A.
    ⁶⁸Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 6, S. 904 - 912
  • Vinsensia, Maria; Chyoke, Peter L.; Hadaschik, Boris; Holland-Letz, Tim; Moltz, Jan Hendrik; Kopka, Klaus; Rauscher, Isabel; Mier, Walter; Schwaiger, Markus C.; Haberkorn, Uwe; Mauer, Tobias; Kratochwil, Clemens; Eiber, Matthias J.; Giesel, Frederik Lars
    68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 12, S. 1949 - 1955
  • Radtke, Jan Philipp; Wiesenfarth, Manuel; Kesch, Claudia; Freitag, Martin T.; Alt, Celine D.; Celik, Kamil; Distler, Florian; Roth, Wilfried; Wieczorek, Kathrin; Stock, Christian; Duensing, Stefan; Roethke, Matthias C.; Teber, Dogu; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Bonekamp, David; Hadaschik, Boris
    Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer : Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies
    In: European Urology Jg. 72 (2017) Nr. 6, S. 888 - 896
  • Roth, Wilfried; Duensing, Stefan; Macher-Goeppinger, Stephan; Falkenstein, Michael; Walter, Britta; Schecher, Sabrina; Tagscherer, Katrin E.; Hadaschik, Boris; Stenzel, Philipp; Perner, Sven; Kristiansen, Glen; Krümpelmann, Kristina
    Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer
    In: International Journal of Cancer Jg. 141 (2017) Nr. 8, S. 1643 - 1653
  • Ganzer, R.; Franiel, T.; Köllermann, J.; Kuru, T.; Baumunk, D.; Blana, A.; Hadaschik, Boris; von Hardenberg, J.; Henkel, T.; Köhrmann, K.-U.; Liehr, U.-B.; Machtens, S.; Roosen, A.; Salomon, G.; Schlemmer, H.-P.; Sentker, L.; Wendler, J.; Witzsch, U.; Schostak, M.
    Fokale Therapie des Prostatakarzinoms
    In: Der Urologe Jg. 56 (2017) Nr. 10, S. 1335 - 1346
  • Schäfer, Martin; Giesel, Frederik L.; Hadaschik, Boris; Ellert, Elena; Kopka, Klaus; Schlemmer, Heinz P.; Radtke, Jan P.; Kesch, Claudia; Vinsensia, Maria; Heller, Martina; Neels, Oliver C.; Cardinale, Jens; Grabe, Nils; Afshar-Oromieh, Ali; Kratochwil, Clemens; Holland-Letz, Tim; Duensing, Stefan; Hohenfellner, Markus; Haberkorn, Uwe; Wieczorek, Kathrin
    Intraindividual Comparison of18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer : A Retrospective, Proof-of-Concept Study
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) S. 1805 - 1810
  • Heußer, Thorsten; Mann, Philipp; Rank, Christopher M.; Schäfer, Martin; Dimitrakopoulou-Strauss, Antonia; Schlemmer, Heinz-Peter; Hadaschik, Boris; Kopka, Klaus; Bachert, Peter; Kachelrieß, Marc; Freitag, Martin T.
    Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI
    In: PLoS ONE Jg. 12 (2017) Nr. 8, S. e0183329
  • Bergero, Miguel A.; Martínez, Pablo F.; Radtke, Jan P.; Hadaschik, Boris
    Multiparametric-MRI-guided biopsy in the era of precision medicine
    In: Archivos Espanoles de Urologia Jg. 70 (2017) Nr. 10, S. 833 - 844
  • Nyarangi-Dix, Joanne N.; Steimer, J.; Bruckner, Thomas M.; Jakobi, Hildegard; Koerber, Stefan Alexander; Hadaschik, Boris; Debus, Debus, Jürgen P.; Hohenfellner, Markus R.
    Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime
    In: World Journal of Urology Jg. 35 (2017) Nr. 12, S. 1841 - 1847
  • Hadaschik, Boris; Herrmann, Ken
    Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
    In: European Urology Jg. 72 (2017) Nr. 3, S. 470 - 471
  • Distler, Florian A.; Radtke, Jan P.; Bonekamp, David; Kesch, Claudia; Schlemmer, Heinz-Peter; Wieczorek, Kathrin; Kirchner, Marietta; Pahernik, Sascha; Hohenfellner, Markus; Hadaschik, Boris
    The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction
    In: The Journal of Urology Jg. 198 (2017) Nr. 3, S. 575 - 582
  • Ceci, Francesco; Herrmann, Ken; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano
    Therapy assessment in prostate cancer using choline and PSMA PET/CT
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. Suppl. 1, S. S78 - S83
  • Grummet, Jeremy; Pepdjonovic, Lana; Huang, Sean; Anderson, Elliot; Hadaschik, Boris
    Transperineal vs. transrectal biopsy in MRI targeting
    In: Translational Andrology and Urology Jg. 6 (2017) Nr. 3, S. 368 - 375
  • Vorworte / Nachworte

  • Seifert, Robert; Eiber, Matthias; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang
    The novel PROMISE framework for PSMA-PET reporting : Ready for the clinical routine?
    In: Clinical and Translational Imaging Jg. 12 (2024) Nr. 1, S. 1 - 3
  • Krafft, Ulrich; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken
    A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
    In: European Urology (2023) in press
  • Hadaschik, Boris; Merseburger, Axel
    Das metastasierte kastrationsresistente Prostatakarzinom : praxisrelevante Hilfestellungen für individuelle Therapieentscheidungen
    In: Die Urologie Jg. 62 (2023) Nr. 12, S. 1267 - 1268
  • Hadaschik, Boris; Stief, Christian
    Aktuelle Bildgebung für Urologen : Moderne Diagnostik in Praxis und Klinik
    In: Der Urologe Jg. 61 (2022) Nr. 4, S. 355 - 356
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    Correction to : COVID-19 research ; promising tracks leading to uro-oncology
    In: International Urology and Nephrology Jg. 53 (2021) Nr. 1, S. 95
  • Thomas, Christian; Hadaschik, Boris
    Oligometastasierte und lokal fortgeschrittene urologische Tumoren : Moderne Diagnostik vor individualisierter multimodaler Therapie
    In: Der Urologe Jg. 60 (2021) Nr. 12, S. 1525 - 1526
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    COVID-19 research : promising tracks leading to uro-oncology
    In: International Urology and Nephrology Jg. 52 (2020) Nr. 6, S. 995 - 997
  • Vaz, Sofia; Hadaschik, Boris; Gabriel, Michael; Herrmann, Ken; Eiber, Matthias; Costa, Durval
    Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 1, S. 9 - 15
  • Fanti, Stefano; Hadaschik, Boris; Herrmann, Ken
    Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression Criteria
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 678 - 682
  • Hadaschik, Boris; Merseburger, A.S.
    Therapie des oligo- und polytopmetastasierten Prostatakarzinoms
    In: Der Urologe Jg. 59 (2020) Nr. 6, S. 657 - 658
  • Hadaschik, Boris; Stief, C.G.
    Management des lokal begrenzten Prostatakarzinoms
    In: Der Urologe Jg. 58 (2019) Nr. 5, S. 485
  • Hadaschik, Boris; Boegemann, Martin
    Why targeting of PSMA is a valuable adDition to the management of castration-resistant prostate cancer : The urologist's point of view
    In: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 8, S. 1207 - 1209
  • Abstracts

  • Handke, A.; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Y.; Hakansson, A.; Davicioni, E.; Hughes, J.; Song, H.; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert;
    Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S180
  • Gafita, A.; Djaileb, L.; Rauscher, I.; Hadaschik, Boris; Herrmann, Ken; Weber, Manuel;
    Assessment of Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-Resistant Prostate Cancer
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S544 - S545
  • Heitmann, J. S.; Hackenbruch, C.; Walz, J. S.; Federmann, B.; Pfluegler, M.; Schlenk, R. F.; Ochsenreither, S.; Hadaschik, Boris; Darr, Christopher; Grünwald, Viktor; Jung, G.; Salih, H. R.;
    Clinical development of the bispecific PSMAxCD3 antibody CC-1 for treatment of prostate cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 112
  • Schürger, N.; Darr, Christopher; Möller, L.; Reis, H.; Isgandarov, A.; Thomas, H.; Stang, Andreas; Hadaschik, Boris; Kajüter, H.; Grünwald, Viktor;
    Histotype-specic overall survival of patients with urothelial carcinoma from the largest EU cancer registry in North Rhine-Westphalia, Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 321 - 322
  • Pedro, Costa Fragoso; Darr, Christopher; Moraitis, Alexandros; Kahl, T.; Engel, J.; Al-Nader, Mulham; Henning, Monika; Köllermann, J.; Kesch, Claudia; Krafft, Ulrich; Maurer, T.; Köhler, D.; Klutmann, S.; Falkenbach, F.; Kleesiek, Jens; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris;
    Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S586
  • Farolfi, Andrea; Armstrong, Wesley; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Auerbach, Martin; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias;
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P843
  • Farolfi, A.; Armstrong, W.; Djaileb, L.; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, S. S92
  • Darr, C.; Fragoso Costa, P.; Kahl, T.; Alexandros, M.; Fendler, Wolfgang P.; Barbato, F.; Bartel, T.; Reis, H.; Köllermann, J.; Pullen, L.; Kesch, C.; Krafft, Ulrich; Kleesiek, Jens; Herrmann, Ken; Hadaschik, Boris A.;
    Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
    38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,
    In: European Urology Jg. 83 (2023) Nr. Supplement 1, S. S687
  • Váradi, M.; Horváth, O.; Fazekas, T.; Csizmarik, A.; Módos, O.; Széles, Á.; Kenessey, I.; Reis, H.; Oláh, C.; Hadaschik, Boris; Krafft, Ulrich; Ting, S.; Furka, A.; Nyirády, P.; Szarvas, T.;
    Molecular analysis of urothelial carcinoma to predict the efficacy of immune checkpoint inhibitor therapy
    38th Annual European Association of Urology Congress (EAU) ; March 10 - 13, 2023, Milan, Italy,
    In: European Urology Jg. 83 (2023) Nr. Supplement 1: Abstracts EAU23, S. S1679 - S1680
  • Pöttgen, Christoph; Khouya, Aymane; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago, Alina; Krafft, Ulrich; Hadaschik, Boris; Stuschke, Martin
    Online-adaptive Strahlentherapie beim muskelinvasiven Blasenkarzinom mit angepassten PTVSäumen : Vorteil gegenüber der IGRT zum Zeitpunkt der Adaptation und gute akkumulierte EUD zum Zeitpunkt der Applikation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S153
  • Moraitis, Alexandros; Darr, Christopher; Kahl, T.; Püllen, Lukas; Jentzen, Walter; Kersting, David; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; Costa, Pedro Fragoso;
    Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S131
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Calais, Jeremie; Rowe, Steven; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias; Farolfi, Andrea;
    Practical RECIP : Visual assessment of Response Evaluation Criteria In PSMA-PET/CT in metastatic castration-resistant prostate cancer
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P1619
  • Fendler, Wolfgang; Seifert, Robert; Emmett, Louise; Herrmann, Ken; Hadaschik, Boris; Eiber, Matthias
    Prostate Cancer Molecular Imaging Standardized Evaluation : The PROMISE V2 Framework Including Response Evaluation for Clinical Trials
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S150
  • Afferi, L.; Spahn, M.; Hayoz, S.; Hadaschik, Boris; Cathomas, R.; et al.;
    Surgical safety and quality of radical cystectomy and pelvic lymph node dissection after neoadjuvant Durvalumab and Cisplatin/Gemcitabine for muscle invasive bladder cancer : Results from the SAKK 06/17 phase II study
    38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,
    In: European Urology Jg. 83 (2023) Nr. Supplement 1, S. S230 - S231
  • Seifert, Robert; Emmett, L.; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang;
    The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S177
  • Darr, C.; Zschäbitz, S.; Niegisch, G.; Roghmann, F.; Ivanyi, P.; Zengerling, F.; Paffenholz, P.; Biernath, N.; Klee, M.; Klümper, N.; Tauber, R.; Hadaschik, Boris; Hilser, T.; Grünwald, V.;
    Enfortumab Vedotin bei metastasiertem Urothelkarzinom : retrospektive, multizentrische Patientenkohorte
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 64
  • Darr, C.; Zschäbitz, S.; Niegisch, G.; Roghmann, F.; Ivanyi, P.; Zengerling, F.; Paffenholz, P.; Biernath, N.; Klee, M.; Klümper, N.; Tauber, R.L.; Hadaschik, Boris; Hilser, T.; Grünwald, V.;
    Enfortumab vedotin in metastatic urothelial carcinoma : Retrospective multicentre patient cohort
    Annual Meeting of the European-Society-for-Medical-Oncology (ESMO): SEP 09-13, 2022; Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1342
  • Pabst, K. M.; Fendler, Wolfgang P.; Hadaschik, Boris; Kesch, C.; Hirmas, N.; Kessler, Lukas; Gruenwald, V.; Hamacher, R.; Nader, M.; Berliner, C.; Umutlu, Lale; Püllen, Lukas; Herrmann, Ken; Lückerath, Katharina; Castellucci, P.; Fanti, S.; Mei, R.;
    FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S118 - S119
  • Zeuschner, P.; Siemer, S.; Stöckle, M.; Schiefelbein, F.; Schneller, A.; Schön, G.; Wiesinger, C.; Pfuner, J.; Ubrig, B.; Gloger, S.; Osmonov, D.; Eraky, A.; Witt, J.; Liakos, N.; Wagner, C.; Hadaschik, Boris; Radtke, J.P.; Al Nader, M.; Imkamp, F.; Kuczyk, M.; Huusmann, S.; Harke, N.;
    Impact of surgical experience prior to robot-assisted partial nephrectomy on surgical outcomes : Large multicenter analysis with 2,500 patients
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S191 - S192
  • Schürger, N.; Darr, C.; Möller, L.; Reis, Henning; Isgandarov, A.; Hilser, Thomas; Stang, Andreas; Hadaschik, Boris; Kajüter, H.; Grünwald, V.;
    Inzidenz und Überleben von Patienten mit Urothelkarzinom in Nordrhein-Westfalen (NRW) : Analyse des Landeskrebsregister (LKR) von den Jahren 2008-2019
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 318
  • Isgandarov, A.; Darr, C.; Hilser, T.; Al-Nader, M.; Hadaschik, Boris A.; Grünwald, V.;
    Klinische Wirksamkeit kontemporärer Systemtherapie mit Immuntherapie beim metastasierten Urothelkarzinom, eine monozentrische Evaluation
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 318
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.R.; Tauber, R.; Grogan, T.R.; Czernin, J.; Rettig, M.B.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.R.; Fendler, Wolfgang; Eiber, M.;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : An international multicenter study
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S794 - S795
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.; Tauber, R.; Grogan, T.; Czernin, J.; Rettig, M.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.; Fendler, Wolfgang; Eiber, M.;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S269
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley Robert; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias; Fendler, Wolfgang; Eiber, Matthias;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    2022 ASCO Genitourinary Cancers Symposium, 17.-19.02.2022, San Fransisco,
    In: Journal of Nuclear Medicine (JNM) Jg. 40 (2022) Nr. 6, Supplement: 2022 ASCO Genitourinary Cancers Symposium, jnumed.121.263072
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6, 42
  • Cathomas, Richard; Rothschild, Sacha; Hayoz, Stefanie; Spahn, Martin; Özdemir, Berna; Kiss, Bernhard; Erdmann, Andreas; Aeppli, Stefanie; Mach, Nicolas; Strebel, Raeto; Hadaschik, Boris; Berthold, Dominik R.; Pless, Miklos; Zihler, Deborah; Schmid, Mathias; Schneider, Martina; Musilova, Jana; Petrausch, Ulf
    Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC) : Primary analysis of the single arm phase II trial SAKK 06/17
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 4515
  • Maier, D.; Vehreschild, J. J.; Uhl, B.; Grünwald, V.; Hadaschik, Boris; Palm, S.; Stuschke, Martin; Esins, M.; Ressing, F.; Schuler, Martin; Serve, H.; et al.;
    Profil der multizentrischen Kohorte der Klinischen Kommunicationsplattform des Deutschen Konsortiums für Translationale Krebsforschung (DKTK)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 13
  • Kesch, C.V.; Pantea, V.; Soeterik, T.; Marquis, A.; La Bombarda, G.; Morlacco, A.; Barletta, F.; Preisser, F.; Zattoni, F.; Marra, G.; Van Den Bergh, R.C.N.; Radtke, J.P.; Hadaschik, Boris; Gandaglia, G.;
    Risk of adverse outcomes after prostatectomy in patients diagnosed with IUSP <= 2 prostate cancer on MRI/TRUS fusion biopsy
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S438
  • Harke, N.N.; Schiefelbein, F.; Schneller, A.; Schoen, G.; Wiesinger, C.G.; Pfuner, J.; Falkensammer, E.; Gilbert, N.; Eraky, A.; Zimmermanns, V.; Paramythelli, I.; Hadaschik, Boris; Radtke, J. P.; Darr, C.; Kriegmair, M.C.; Flintrop, M.; Wolters, M.; Faraj Tabrizi, P.; Kuczyk, M.A.; Osmonov, D.;
    Robot-assisted partial nephrectomy for multiple renal tumors : a multicenter analysis
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S543
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Gruenwald, V.; von Tresckow, Bastian; Hanoun, C.; Aigner, Clemens; Glas, M.; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.;
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120
  • Hamacher, R.; Möller, L.; Kajüter, H.; Eisfeld, C.; Assahub, M.; Darr, C.; Hadaschik, Boris; Bauer, Sebastian; Stang, Andreas; Grünwald, V.;
    Urogenitale Sarkome im Erwachsenenalter : eine populationsbasierte Analyse von Tumorcharakteristika, Inzidenz und Überleben in Nordrhein-Westfalen (NRW)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 63
  • Saner, Y.; Wiesenfarth, M.; Tschirdewahn, Stephan; Püllen, Lukas; Bonekamp, D.; Krafft, Ulrich; Kesch, C.; Darr, C.; Forsting, Michael; Umutlu, Lale; Hadaschik, Boris; Radtke, J. P.
    Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography-fusion biopsy : A prospective, randomized comparison to conventional target biopsy
    In: European Urology Jg. 79 (2021) Nr. Suppl. 1, 4460
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, M.;
    Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    EANM‘21 ; 34th Annual Congress of the European Association of Nuclear Medicine ; October 20-23, 2021, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. S311 - S312
  • Ferdinandus, Justin; Maríc, Ines; Darr, Christopher; Kesch, Claudia; Hilser, Thomas; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor;
    FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma
    2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. Suppl. 15, S. e16564
  • Costa Fragoso, P.; Püllen, Lukas; Klose, J. M.; Iking, J.; Sandach, Patrick; Staniszewska, M.; Herrmann, Ken; Radtke, J. P.; Tschirdewahn, Stephan; Hadaschik, Boris; Fendler, Wolfgang; Darr, C.
    Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse model
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 17
  • Hadaschik, Boris
    Initial experience from a multicentre clinical trial evaluating the safety and performance of a drop-in gamma probe for sentinel lymph node biopsy in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 554
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R; Tauber, Robert; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter study
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 5066 - 5066
  • Hadaschik, Boris; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang
    Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63 - S64
  • Hadaschik, Boris; Fanti, S.; Ost, P.; Tunariu, N.; de Nunzio, C.; Antoni, L.; Lukac, M.; Martin, J.; Pissart, G.; Wapenaar, R.; Mottet, N.
    PRIMORDIUM : A randomized, international, trial-in-progress of adding apalutamide to radiotherapy and an LHRH agonist in high-risk patients with PSMA-PET-positive hormone-sensitive prostate cancer
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 676 - S677
  • Calais, Jeremie; Zhu, Shaojun; Hrimas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study Protocol
    In: Cancer Research Jg. 81 (2021) Nr. 13, CT257
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar Upadhyaya; Nickols, Nicholas George; Elashoff, David; Fendler, Wolfgang;
    Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
    2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 6, Supplement, S. TPS172
  • Junquera, Jose Maria Abascal; Walz, Jochen Christoph; Hadaschik, Boris; Adshead, Jim; Everaerts, Wouter; Goffin, Karolien; Grootendorst, Maarten Ruben; Oldfield, Francesca; Fusco, Antoni Mestre; Vidal-Sicart, Sergi; Fumado, Lluis
    The SENSEI laparoscopic tethered gamma probe for sentinel lymph node biopsy in prostate cancer : Initial experience from a multicenter clinical trial
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 899
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie N; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; De Porre, Peter; Smith, Andressa; Brookman-May, Sabine Doris; Li, Susan; Zhang, Ke; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Smith, Matthew Raymond
    Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 5516
  • Oudard, S.; Hadaschik, Boris; Saad, Fred; Cella, David; Basch, Ethan; Mainwaring, Paul; Graff, J.N.; Dibaj, Seyedeh S.; Li, S.; Brookman-May, S.D.; De Porre, P.; Trudeau, Jeremiah J.; Small, E.J.; Smith, Mitchell R.
    Health-related quality of life (HRQoL) at final analysis of the SPARTAN study of apalutamide (APA) vs placebo (PBO) in patients (pts) with non-metastatic castration-resistant prostate cancer (nmCRPC) receiving androgen deprivation therapy (ADT)
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S521
  • Farolfi, Andrea; Barbato, Francesco; Weber, Manuel; Ferdinandus, Justin; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang
    Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PET
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1270
  • Hadaschik, Boris
    Molecular determinants of prostate specific antigen (PSA) kinetics and clinical response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in SPARTAN
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl.,
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Ferdinandus, Justin; Nader, Michael; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang
    PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imaging
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1260
  • Uemura, H.; Lee, J. Y.; Oudard, S.; Hadaschik, Boris A.; Saad, F.; Cella, D.; Basch, E.; Graff, J. N.; Dibaj, S.; Li, S.; Brookman-May, S. D.; De Porre, P.; Bevans, K.; Trudeau, J.; Smith, M. R.; Small, E. J.;
    Patient-reported sexual and urinary function in nonmetastatic castration-resistant prostate cancer (nmCRPC) when treated with apalutamide (APA) vs placebo (PBO) and ongoing androgen deprivation therapy (ADT) in SPARTAN
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Supplement 6, S. S1327
  • Fragoso Costa, P.; Sonnenschein, W.; Binse, Ina; Fendler, W. P.; Herrmann, Ken; Grootendorst, M. R.; Krafft, Ulrich; Radtke, J. P.; Hadaschik, Boris; Darr, C.;
    Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S212
  • Feng, Felix; Thomas, Shibu; Gormley, Michael; Lopez-Gitlitz, Angela; Yu, Margaret K.; Cheng, Shinta; Ricci, Deborah S.; Rooney, Brendan; Mainwaring, Paul N.; Olmos, David; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris; Fishbane, Nick; Davicioni, Elai; Liu, Yang; Small, Eric J.; Smith, Matthew R.
    Abstract CT129: (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the SPARTAN study
    In: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
  • Graff, Julie Nicole; Smith, Matthew Raymond; Saad, Fred; Hadaschik, Boris; Uemura, Hiroji; Lee, Ji Youl; Mainwaring, Paul N.; Olmos, David; Oudard, Stephane; Londhe, Anil; Bhaumik, Amitabha; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Small, Eric Jay
    Age-related efficacy and safety of apalutamide (APA) plus ongoing androgen deprivation therapy (ADT) in subgroups of patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Post hoc analysis of SPARTAN
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 5024 - 5024
  • Pollock, YaoYao Guan; Smith, Matthew Raymond; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Mundle, Suneel; Cheng, Shinta; Small, Eric Jay
    Predictors of falls and fractures in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with apalutamide (APA) plus ongoing androgen deprivation therapy (ADT)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 5025 - 5025
  • Small, Eric Jay; Cella, David F.; McQuarrie, Kelly; Saad, Fred; Hadaschik, Boris; Graff, Julie N.; Uemura, H.; Oudard, Stephané Marie; Yu, M.K.; Hudgens, Stacie A.; Lopez-Gitlitz, Angela; Rooney, B.; Morris, Michael J.; Smith, Matthew Raymond
    Health-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN : A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii276 - viii277
  • Small, Eric Jay; Saad, Fred; Zheng, Ying; Pan, Feng; Mehra, Maneesha; Lawson, Joe; Hadaschik, Boris; Uemura, Hiroji; Lee, Ji Youl; Mainwaring, Paul N.; Smith, Matthew Raymond
    Impact of intervening in high-risk nonmetastatic castration-resistant prostate cancer (HRnmCRPC) on metastatic castration-resistant prostate cancer (mCRPC) disease burden
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e17010 - e17010
  • Afshar-Oromieh, A.; Debus, N.; Uhrig, M.; Hope, T.A.; Evans, M. J.; Holland-Letz, T.; Giesel, F.; Kopka, K.; Hadaschik, Boris; Kratochwil, C.; Haberkorn, U.
    Impact of long-term androgen deprivation therapy on PSMA-ligand PET/CT in patients with castration sensitive prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 22 - S23
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor;
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378
  • Small, Eric Jay; Saad, Fred; Rathkopf, Dana E.; Hadaschik, Boris; Chowdhury, Simon; Yu, Margaret K.; Lopez-Gitlitz, Angela; Rooney, Oliver Brendan; Shu, Youyi; Darif, Mohamed; Smith, Matthew Raymond
    Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) : An analysis from the phase 3 SPARTAN trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 5034 - 5034
  • Smith, Matthew Raymond; Saad, Fred; Rathkopf, Dana E.; Hadaschik, Boris; Chowdhury, Simon; Yu, Margaret K.; Lopez-Gitlitz, Angela; Rooney, Oliver Brendan; Darif, Mohamed; Small, Eric Jay
    Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) : Results from the phase 3 SPARTAN trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 5033 - 5033
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris A.; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Uemura, Hiroji; Lopez-Gitlitz, Angela; Trudel, Geralyn Carol; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.; Smith, Matthew Raymond
    SPARTAN, a phase 3 double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 6 Suppl., S. 161
  • Hadaschik, Boris; Small, E. J.; Saad, F.; Chowdhury, S.; Graff, J. N.; Olmos, D.; Mainwaring, P. N.; Uemura, H.; Lopez-Gitlitz, A.; Trudel, G. C.; Espina, B. M.; Shu, Y.; Park, Y. C.; Rackoff, W. R.; Yu, M. K.; Smith, M. R.; SPARTAN Investigators;
    SPARTAN, a phase 3 double-blind, randomized study of apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 43
  • Beiträge in Sammelwerken und Tagungsbänden

  • Schostak, M.; Wendler, J.J.; Baumunk, D.; Blana, A.; Ganzer, R.; Franiel, T.; Hadaschik, Boris; Henkel, T.; Köhrmann, K.U.; Köllermann, J.; Kuru, T.; Machtens, S.; Roosen, A.; Salomon, G.; Schlemmer, H.P.; Sentker, L.; Witzsch, U.; Liehr, U.B.
    Treatment of Small Renal Masses
    In: Urologic Oncology / Merseburger, Axel S.; Burger, Maximilian 2019, S. 555 - 568
  • Schütz, Viktoria; Kesch, Claudia; Dieffenbacher, Svenja; Bonekamp, David; Hadaschik, Boris; Hohenfellner, Markus; Radtke, Jan Philipp
    Multiparametric MRI and MRI/TRUS Fusion Guided Biopsy for the Diagnosis of Prostate Cancer
    In: Molecular & Diagnostic Imaging in Prostate Cancer: Clinical Applications and Treatment Strategies / Schatten, Heide (Hrsg.) 2018, S. 87 - 98